rfhg_163259.1

Basic information about the TSS

---

TSS ID: rfhg_163259.1 TSS ID(Version3): hg_138431.1 hg_235039.1 hg_138430.1 Species: human Chr: chr14		Start: 20455186 End: 20455274 Strand: +
Source datasets	DRA000914|PRJNA597322|PRJNA401781|DRA013844|PRJNA615891 |PRJNA4843412|PRJNA548673|PRJDB5282
Protocol	CAGE|STRIPE-seq|RAMPAGE|oligo_capping|TIF-seq2|NETCAGE |ReCappable-seq|C1CAGE|SLIC_CAGE
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2697587,EH38E1700982)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000555414.5:0 ENST00000553681.5:0 ENST00000554813.5:0 ENST00000556296.1:0 ENST00000557344.5:0 ENST00000555306.5:0 ENST00000553555.5:0 ENST00000216714.8:0 ENST00000398030.8:0 ENST00000554325.1:0 ENST00000557181.5:0 ENST00000555839.5:0 ENST00000557159.5:0 ENST00000553368.1:0 ENST00000556054.5:0 ENST00000557054.1:0 ENST00000557592.5:0 ENST00000557365.1:0 ENST00000557150.5:0 AK098588:0 AK291100:0 BC095428:0 AK311548:0 BX161454:0 S43127:0 BC002338:0 BC019291:0 BC008145:0 M81955:0 X59764:0 D90373:0 BC004979:0 GeneID: 328 HGNC/MGI_ID: HGNC:587 UniProt_ID: A0A0C4DGK8 G3V2D9 G3V359 G3V3C7 G3V3M6 G3V3Y6 G3V574 G3V5D9 G3V5M0 G3V5Q1 Q5TZP7 Nearer transcript ids and distances: M80261:7 U79268:11 KJ890683:369 KJ896440:369 KR709886:369 KR709887:369 KR709888:369 KR709889:369 AB463413:372 BT007236:372 BT020133:372 DQ891814:372 DQ894998:372 view more...

Gene_name: apurinic/apyrimidinic endodeoxyribonuclease 1 Gene_symbol: APEX1 Gene_synonyms: APE APE-1 APEN APX HAP1 REF-1 REF1 Gene_source: HGNC:587

TATA-Box annotation

---

Distance to TSS:	4
Nearest PromoterID:	NM_001641
Entrez ID:	328
Nearest Unigene:	Hs.73722
Nearest Refseq:	NM_001641
Nearest Ensembl:	ENSG00000100823
Gene Name:	apurinic/apyrimidinic endodeoxyribonuclease 1
Gene Alias:	APE|APE1|APEN|APEX|APX|HAP1|REF1
Gene Type:	protein-coding
CpG%:	0.068182
GC%:	0.662921
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@APEX1 p2@APEX1 p3@APEX1 p4@APEX1 p5@APEX1 p6@APEX1
Sample		p1@APEX1	p2@APEX1	p3@APEX1	p4@APEX1	p5@APEX1	p6@APEX1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	113.18	7.60	0.78	15.19	0.19	0.78
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	116.13	7.69	0.61	15.78	0.40	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	117.67	7.14	0.96	18.52	0.19	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	98.76	6.45	0.83	11.85	0.42	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	115.86	9.22	1.12	12.37	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	107.76	6.01	1.16	13.37	0.00	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	159.27	9.15	1.74	24.19	0.65	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	128.86	6.30	0.73	19.62	0.00	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	127.59	6.41	0.00	16.03	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	89.84	5.22	0.58	8.69	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	81.66	2.83	0.00	8.08	0.81	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	66.67	2.44	1.22	11.79	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	142.01	5.32	0.81	5.16	0.64	1.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	163.28	7.07	0.60	3.76	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	141.61	7.90	1.32	3.51	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	137.82	6.79	0.50	5.53	0.75	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	139.34	10.48	0.66	3.93	0.44	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	117.69	13.50	0.84	3.80	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	124.76	10.13	0.00	5.86	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	122.46	6.62	0.30	4.51	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	133.52	10.29	0.53	5.21	0.40	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	145.18	9.32	0.17	6.04	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	144.25	8.14	0.65	4.78	0.00	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	144.87	6.31	0.24	3.15	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	125.38	8.51	0.77	6.97	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	114.26	8.86	0.63	3.17	0.32	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	125.28	10.44	0.00	5.49	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	157.01	8.25	0.71	6.13	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	105.80	6.95	0.65	4.52	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	141.52	9.05	1.27	5.79	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	107.39	7.96	0.00	4.81	0.84	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	99.45	5.28	0.59	2.74	0.00	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	102.77	4.85	0.42	5.91	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	183.91	9.90	1.65	5.94	0.16	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	124.35	6.17	1.12	4.67	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	115.93	6.13	1.15	5.94	0.19	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	128.35	7.97	0.82	6.34	0.00	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	126.13	7.25	0.40	5.84	0.20	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	113.44	9.18	0.54	5.67	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	123.87	8.88	0.96	5.04	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	113.16	7.53	0.71	3.53	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	152.69	9.81	0.88	6.15	0.29	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	101.86	5.27	0.42	3.80	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	96.85	7.34	0.35	3.85	0.17	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	109.42	7.83	0.00	5.82	0.40	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	109.81	4.19	0.93	5.35	0.70	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	96.92	8.16	0.24	6.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	95.67	5.66	0.30	5.66	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	85.94	5.74	0.24	4.79	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	85.53	7.48	0.20	4.45	0.20	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	73.78	6.35	0.20	3.07	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	91.84	11.56	0.89	4.67	1.11	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1623.09	41.98	27.98	41.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	83.39	4.61	0.71	4.97	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	76.55	5.63	1.33	3.65	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	494.13	30.20	7.55	20.13	5.87	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	163.49	18.83	3.21	11.02	0.92	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	70.33	5.83	0.65	5.19	0.65	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	73.87	4.50	0.96	2.57	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	147.42	14.77	0.94	9.43	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	69.10	7.05	2.12	5.64	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	76.27	6.17	1.12	2.80	1.12	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	296.17	36.62	3.98	11.15	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	95.47	11.55	2.72	6.46	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	51.01	5.20	0.65	1.95	0.32	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	63.54	5.32	0.35	3.19	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1438.59	32.33	0.00	32.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1105.65	71.08	7.90	23.69	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	46.31	4.39	1.46	2.44	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	55.54	5.45	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	52.07	7.51	0.47	0.94	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	58.29	10.93	0.66	1.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	38.05	4.33	1.86	2.47	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	43.11	10.70	0.31	1.83	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	89.49	19.64	0.32	3.96	0.16	0.16
Adipocyte - breast, donor2	11327-117E4	78.45	15.56	2.73	5.29	0.32	0.96
Adipocyte - omental, donor1	11473-119C6	90.97	22.01	0.38	5.47	0.13	0.25
Adipocyte - omental, donor2	11474-119C7	56.06	7.47	0.75	5.23	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	77.03	15.41	0.67	5.69	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	50.40	17.23	1.91	1.91	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	59.37	11.00	1.10	3.30	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	133.23	18.97	0.45	8.13	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	166.65	8.34	0.52	5.91	0.17	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	145.51	23.08	0.00	6.65	0.20	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	103.72	18.53	0.26	5.40	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	117.08	14.22	0.00	2.79	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	128.73	21.75	1.18	5.29	1.18	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	156.04	28.55	0.80	9.33	0.16	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	115.87	15.17	0.65	4.52	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	110.90	16.00	0.53	3.73	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	107.95	10.57	0.56	3.34	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	105.64	17.47	0.83	4.57	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	87.91	13.06	0.75	5.53	0.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	100.46	18.98	0.65	4.91	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	72.46	15.22	1.22	4.87	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	173.70	25.86	1.99	16.35	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	65.62	11.83	0.00	11.12	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	85.06	7.19	0.00	7.19	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	150.40	11.51	0.54	11.33	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	182.41	16.73	0.00	11.71	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	151.00	14.79	0.21	4.52	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	217.41	20.37	0.69	7.21	0.00	0.23
Anulus Pulposus Cell, donor2	11463-119B5	110.70	20.82	0.49	5.14	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	101.99	17.97	2.25	7.64	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	111.57	23.01	0.87	9.99	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	70.63	25.68	0.00	6.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	113.29	17.64	2.99	5.98	0.00	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	123.94	16.44	1.26	5.06	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	92.41	11.88	0.00	4.62	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	94.22	18.84	0.97	5.20	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	115.53	12.62	0.97	3.88	0.49	0.49
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	96.21	19.60	1.78	4.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	117.13	13.18	2.26	6.40	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	102.32	11.61	1.45	5.08	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	91.53	15.05	2.51	7.52	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	130.31	21.75	0.33	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	72.33	16.38	2.73	8.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	82.18	14.48	0.45	5.28	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	81.44	19.29	2.68	5.89	0.00	1.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	99.19	18.33	0.57	5.48	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	86.87	17.91	0.53	4.81	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	79.01	23.41	0.00	4.88	0.98	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	101.84	18.91	1.16	5.14	0.17	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	87.65	19.21	1.20	3.60	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	56.64	28.32	0.00	7.08	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	94.86	16.98	0.51	3.95	0.00	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	125.85	29.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	97.08	18.93	1.94	5.34	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	146.09	26.56	1.90	8.35	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	107.81	19.38	0.00	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	99.76	19.38	0.00	7.41	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	88.72	19.67	1.28	5.56	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	74.85	18.32	1.03	3.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	88.21	14.08	0.00	6.10	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	97.43	18.33	0.96	3.54	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	87.04	16.41	0.71	7.13	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	89.50	15.79	1.17	8.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	93.93	18.06	1.51	4.22	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	108.11	16.63	1.19	3.56	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	138.33	20.85	2.03	8.65	0.51	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	128.36	22.92	1.27	6.88	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	82.60	19.70	1.27	8.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	99.25	16.83	0.86	8.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	102.67	19.05	0.42	6.77	0.21	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	73.95	14.50	0.00	3.48	0.00	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	92.58	11.34	0.94	10.39	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	88.83	17.80	0.17	5.59	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	111.19	20.85	6.95	4.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	88.73	19.01	0.00	6.34	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	99.27	14.37	1.07	6.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	81.22	19.25	1.20	4.81	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	94.77	16.77	2.19	8.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	127.35	21.84	1.61	5.06	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	81.61	17.85	5.10	7.65	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	76.27	17.03	0.00	4.07	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	98.47	19.41	0.62	6.40	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	93.94	16.22	0.92	3.98	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	102.77	18.64	2.39	6.21	0.96	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	87.14	17.96	0.44	5.99	0.22	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	90.02	12.21	1.53	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	93.61	19.39	0.55	9.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	91.88	16.68	0.79	3.71	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	75.60	13.45	1.09	8.00	0.00	0.73
Astrocyte - cerebellum, donor1	11500-119F6	386.38	26.77	1.11	27.02	0.00	0.61
Astrocyte - cerebellum, donor2	11580-120F5	213.27	16.77	0.34	20.37	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	173.46	7.76	0.42	7.97	0.21	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	271.20	13.94	0.35	14.64	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	235.22	18.44	2.43	13.59	0.16	0.49
Astrocyte - cerebral cortex, donor3	11392-118C6	211.21	11.93	1.94	12.38	0.30	0.45
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	214.12	2.98	2.18	11.47	0.46	0.23
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	248.93	7.02	2.00	15.91	0.75	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	239.31	4.67	1.82	13.20	0.11	0.11
Basophils, donor1	12241-129G9	82.64	6.28	0.26	1.05	0.26	0.00
Basophils, donor2	12242-129H1	132.77	13.35	0.00	1.80	0.36	0.00
Basophils, donor3	12243-129H2	102.31	6.76	0.15	1.91	0.15	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	99.18	14.23	0.22	4.74	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	43.43	4.11	0.00	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	136.30	21.52	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	73.44	15.69	0.63	5.65	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	93.99	15.18	0.42	6.45	0.21	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	67.71	8.29	0.46	2.53	0.00	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	114.27	10.80	1.08	4.14	0.00	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	394.19	5.05	1.13	20.30	0.21	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	397.57	19.56	1.16	34.24	0.23	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	507.16	24.94	0.00	26.22	0.64	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	754.96	41.37	0.00	41.37	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	93.55	6.76	0.56	2.25	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	75.35	5.94	0.93	0.56	0.00	0.37
CD14+ Monocytes, donor3	11381-118B4	59.93	6.59	0.00	1.76	0.66	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	78.12	10.76	0.57	2.26	0.00	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	106.52	14.03	0.38	2.27	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	75.28	9.86	0.33	2.30	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	47.41	3.32	0.58	0.43	0.14	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	68.19	3.62	0.91	0.91	0.30	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	51.17	4.97	0.47	0.71	0.24	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	31.14	2.68	0.33	0.67	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	48.58	2.21	0.28	0.28	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	37.93	2.48	0.00	0.00	0.25	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	27.22	1.76	0.00	0.78	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	47.72	4.81	0.18	0.71	0.36	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	54.63	5.44	0.00	0.87	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	44.72	1.40	0.00	0.94	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	92.40	7.92	0.00	0.53	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	61.01	3.33	1.11	2.22	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	43.14	3.57	0.89	0.00	0.15	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	40.71	2.59	0.60	0.20	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	44.55	3.33	0.00	0.62	0.00	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	36.15	1.83	0.23	0.92	0.23	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	56.32	3.62	0.23	0.68	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	37.54	1.31	0.44	1.31	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	30.13	3.23	0.54	1.61	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	68.74	4.36	0.17	0.70	0.35	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	40.82	4.21	1.26	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	27.19	0.92	0.00	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	34.87	1.41	0.70	1.41	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	21.06	1.75	0.44	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.29	1.92	0.00	0.35	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	58.72	2.60	0.74	1.49	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	63.80	4.10	0.43	1.29	0.00	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	26.21	1.23	0.00	2.46	0.00	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	47.06	4.40	0.00	0.70	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	36.65	1.16	0.23	0.70	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	132.52	6.10	0.22	2.62	0.22	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	131.44	3.46	0.00	3.23	0.23	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	120.87	3.90	0.00	3.47	0.43	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	174.88	10.59	0.31	5.61	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	181.98	8.56	0.00	3.49	0.00	0.87
CD14+CD16- Monocytes, donor3	11910-125G2	162.54	7.36	0.45	5.80	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	76.30	1.53	0.51	1.79	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	93.10	1.76	0.22	2.42	0.22	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	81.27	1.68	0.42	3.37	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	223.55	4.06	0.00	6.10	2.03	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	215.60	7.46	0.00	7.46	0.68	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	235.08	11.39	0.00	10.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	227.61	7.46	0.00	7.46	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	315.74	5.36	0.54	9.11	0.54	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	229.53	4.91	0.70	6.32	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	273.74	6.27	1.57	10.98	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	296.61	7.91	0.00	5.27	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	141.37	7.40	0.00	3.29	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	99.38	13.06	0.73	2.18	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	107.53	7.07	0.50	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	211.73	142.23	1.21	19.39	0.00	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	166.19	108.66	0.40	18.38	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	138.56	10.04	0.00	4.02	0.00	1.00
CD34+ Progenitors, donor2	11625-122B5	328.10	14.61	0.00	5.06	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	544.47	43.96	0.75	29.68	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	561.00	54.34	0.90	36.53	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	138.18	28.21	0.36	4.64	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	96.14	17.76	1.84	1.84	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	101.56	16.77	0.61	2.74	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	159.01	12.51	1.28	6.13	0.26	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	165.75	9.43	0.22	4.94	0.45	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	138.84	8.34	0.29	3.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	157.40	36.51	1.42	5.22	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	198.05	28.80	1.40	3.51	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	141.74	16.48	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	140.61	19.22	0.29	3.47	0.87	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	97.10	12.37	0.17	3.22	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	80.93	9.99	0.48	1.61	0.16	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	87.87	15.24	0.45	2.69	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	102.72	16.42	0.00	2.10	0.70	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	98.56	9.68	1.32	3.52	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	194.38	11.38	0.00	5.06	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	120.51	8.93	0.42	4.99	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	124.30	6.68	1.67	4.01	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	253.17	35.62	1.09	8.43	0.27	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	232.07	27.33	1.07	9.11	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	216.98	30.48	0.00	10.76	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	164.85	13.91	0.74	3.52	0.19	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	127.15	12.56	0.22	3.90	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	118.11	11.56	0.00	3.57	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	141.06	21.74	0.51	2.02	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	166.37	21.66	0.00	2.60	0.43	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	193.94	26.58	0.87	3.92	0.44	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	251.39	15.84	0.49	7.92	0.49	0.99
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	244.64	8.31	0.00	9.23	0.92	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	224.73	8.37	1.40	2.79	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	339.51	15.23	0.28	11.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	335.69	16.93	0.49	9.82	0.00	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	212.52	6.16	0.00	3.08	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	258.92	10.74	0.36	7.52	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	253.45	5.54	0.00	9.69	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	102.80	9.82	0.00	1.96	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	66.45	11.64	0.38	0.75	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	109.33	14.64	0.76	1.51	0.50	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	157.13	21.79	0.92	14.22	0.46	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	146.66	22.77	1.44	13.66	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	154.31	19.97	1.37	13.41	0.55	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	221.26	26.42	1.50	17.41	1.20	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	126.23	14.16	1.20	13.68	1.20	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	137.80	20.01	1.59	12.96	1.14	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	163.40	21.95	0.43	11.95	0.43	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	162.40	28.69	1.32	12.90	0.79	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	159.94	23.45	0.70	15.95	0.94	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	174.79	34.11	0.60	10.87	0.91	0.91
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	155.71	31.08	1.74	11.62	0.29	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	173.98	27.71	2.13	15.99	0.53	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	101.12	16.63	0.44	3.50	20.14	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	82.89	19.13	1.37	3.19	18.22	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	61.91	14.92	1.49	2.24	20.88	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	153.07	17.29	0.36	14.77	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	143.57	14.96	1.15	16.98	1.73	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	133.17	15.32	0.47	11.55	0.71	1.18
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	193.63	20.28	2.54	19.33	2.22	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	159.01	23.37	1.85	16.61	1.23	1.23
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	154.20	18.91	0.96	15.71	0.96	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	126.98	20.27	1.15	9.94	2.29	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	128.48	17.34	0.39	14.58	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	115.73	16.64	2.27	11.35	1.51	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	65.04	24.89	1.61	4.01	14.45	1.61
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	72.04	18.19	0.70	2.80	13.99	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	74.13	24.04	0.00	7.01	25.04	1.00
Cardiac Myocyte, donor1	11525-119I4	78.59	21.93	0.00	3.66	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	138.35	24.21	0.49	6.92	0.00	1.48
Cardiac Myocyte, donor3	11686-122I3	135.64	18.94	0.11	9.16	0.00	0.00
Chondrocyte - de diff, donor1	11261-116G1	113.71	17.33	0.35	9.36	0.69	0.35
Chondrocyte - de diff, donor2	11338-117F6	174.49	11.37	0.71	6.04	0.00	0.71
Chondrocyte - de diff, donor3	11410-118E6	156.45	18.09	0.91	5.80	0.23	0.57
Chondrocyte - re diff, donor2	11339-117F7	270.37	19.70	0.00	11.64	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	78.86	3.64	0.40	3.64	0.00	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	290.45	19.74	1.49	13.77	0.11	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	179.99	24.80	1.92	9.19	0.21	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	198.94	17.97	0.80	9.73	0.09	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	93.90	7.98	0.64	7.79	0.00	0.37
Corneal Epithelial Cells, donor1	11526-119I5	98.59	8.56	0.66	6.37	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	98.97	12.51	1.14	6.83	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	113.24	13.04	0.77	7.16	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	74.46	11.72	0.00	2.15	0.00	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	51.41	11.04	0.32	1.26	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	69.01	6.90	0.00	6.90	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	69.11	14.25	0.32	2.38	0.00	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	190.64	60.47	1.37	2.73	0.00	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	182.15	73.77	1.96	4.57	0.65	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	170.83	78.40	1.45	5.32	0.48	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	152.09	14.18	0.83	12.67	0.00	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	122.64	17.60	0.59	4.69	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	138.01	15.55	0.00	11.59	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	106.16	19.66	0.00	5.50	1.18	0.79
Endothelial Cells - Artery, donor1	11264-116G4	94.53	21.23	0.00	5.24	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	126.34	17.65	1.88	8.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	134.81	17.00	0.70	13.50	0.18	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	106.17	11.53	0.44	5.32	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	97.97	16.73	0.00	5.78	0.30	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	108.25	8.18	0.00	3.10	0.00	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	155.70	19.61	0.59	7.43	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	136.93	19.79	1.56	9.37	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	91.31	6.52	0.14	4.11	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	206.06	24.41	1.60	19.61	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	82.29	15.72	0.52	5.24	0.52	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	216.81	17.77	1.12	14.29	0.00	0.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	153.39	17.38	1.09	13.25	0.22	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	160.84	14.66	0.49	11.11	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	125.13	11.38	1.14	5.69	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	133.41	12.57	0.00	9.78	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	139.11	11.78	0.47	8.16	0.16	0.16
Eosinophils, donor1	12244-129H3	76.23	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	3.30	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	17.83	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	85.51	7.57	0.24	4.40	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	39.52	8.32	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	67.32	18.88	0.00	2.05	0.00	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	32.74	29.23	0.88	1.64	0.55	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	64.03	26.22	0.98	3.90	0.43	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	114.49	37.11	0.36	8.61	0.12	0.97
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	98.26	54.86	0.96	12.15	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	85.75	30.06	1.58	3.27	0.53	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	99.34	23.71	1.05	8.70	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	89.69	18.94	1.00	5.32	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	103.88	19.51	0.91	9.07	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	79.58	18.19	0.00	6.06	0.00	1.52
Fibroblast - Cardiac, donor3	11417-118F4	67.98	15.46	0.16	5.05	0.00	0.16
Fibroblast - Cardiac, donor4	11452-119A3	173.98	33.04	0.30	9.09	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	110.15	15.48	0.76	5.84	0.25	0.76
Fibroblast - Cardiac, donor6	11460-119B2	103.99	19.25	0.76	8.79	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	164.67	26.40	0.54	8.98	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	103.11	11.22	0.43	1.73	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	209.47	19.04	4.39	7.32	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	188.66	7.84	0.69	17.76	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	264.24	19.67	0.51	5.09	0.17	0.51
Fibroblast - Dermal, donor1	11269-116G9	131.71	24.65	1.17	8.45	0.00	0.70
Fibroblast - Dermal, donor2	11346-117G5	191.03	27.36	0.94	16.04	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	127.53	23.45	0.12	9.19	0.24	0.00
Fibroblast - Dermal, donor4	11450-119A1	175.22	13.00	2.15	14.47	0.23	0.00
Fibroblast - Dermal, donor5	11454-119A5	192.60	13.96	1.57	20.59	0.35	0.35
Fibroblast - Dermal, donor6	11458-119A9	222.36	19.33	1.95	24.53	0.00	0.65
Fibroblast - Gingival, donor1	11237-116D4	144.72	23.95	0.62	10.20	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	109.52	22.27	0.52	6.81	0.00	0.26
Fibroblast - Gingival, donor2	11318-117D4	196.62	13.05	4.61	14.76	0.26	0.40
Fibroblast - Gingival, donor3	11394-118C8	152.28	15.66	0.29	7.44	0.48	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	100.77	18.70	0.00	4.16	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	73.65	7.93	0.88	3.00	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	124.87	25.26	0.62	7.95	0.31	0.31
Fibroblast - Gingival, donor6 (control)	11922-125H5	100.20	31.64	0.41	7.71	0.14	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	62.46	17.64	0.00	2.82	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	104.27	27.06	0.29	4.97	0.44	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	131.58	28.50	0.55	6.95	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	132.84	24.68	0.22	9.21	0.55	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	108.00	7.19	0.44	4.84	0.00	0.44
Fibroblast - Lung, donor1	11270-116H1	114.19	6.80	1.36	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	179.06	8.95	0.00	8.95	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	171.15	10.76	0.84	9.50	0.21	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	281.56	49.98	0.00	31.65	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	107.69	23.78	0.00	5.59	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	51.50	11.20	0.28	5.04	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	283.77	41.41	0.41	22.73	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	147.79	15.98	3.99	7.99	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	148.91	17.87	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	221.52	13.77	0.39	22.11	0.39	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	241.33	11.07	3.03	19.87	0.46	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	178.70	29.99	0.61	10.71	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	124.79	17.17	2.29	6.49	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	96.93	21.60	1.35	4.32	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	79.33	8.70	0.35	4.18	0.12	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	132.20	33.38	0.44	10.50	0.00	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	169.26	36.57	1.42	8.94	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	207.81	16.71	1.34	18.71	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	141.54	19.77	0.79	7.91	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	138.91	18.85	1.19	10.32	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	130.90	8.70	0.18	6.04	0.18	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	151.56	21.88	0.59	4.93	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	165.17	20.46	0.60	9.33	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	182.01	26.02	1.30	10.15	0.11	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	119.96	17.46	0.51	6.33	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	121.42	14.93	0.16	5.91	0.00	0.66
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	179.25	27.07	0.80	12.83	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	144.06	34.36	1.00	11.45	0.20	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	168.65	22.97	1.21	11.49	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	148.38	12.18	0.58	5.05	0.00	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	233.69	31.97	0.85	7.01	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	128.09	24.96	0.66	8.87	0.33	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	135.60	33.13	0.32	8.73	0.00	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	161.76	19.23	0.34	11.81	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	153.68	26.03	1.41	5.96	0.63	0.78
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1307.43	132.96	0.00	88.64	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	99.35	5.23	1.74	1.74	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	80.09	16.99	0.52	2.77	0.00	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	96.03	22.38	0.26	3.90	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	81.25	20.95	0.51	5.88	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	258.76	21.44	2.30	11.48	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	308.19	19.78	3.19	14.68	1.91	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	581.94	13.69	3.42	31.66	1.71	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	231.64	12.96	2.48	5.79	0.28	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	155.49	7.76	0.68	6.85	0.46	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	339.79	11.10	2.38	16.44	0.40	1.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	228.39	13.22	0.79	5.82	0.00	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	131.44	7.18	0.98	5.87	0.33	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	459.47	14.59	3.54	20.34	1.77	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	268.79	13.57	2.54	10.60	0.28	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	196.17	9.97	1.48	8.13	0.99	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	233.70	18.54	1.88	11.28	0.54	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	180.64	9.04	0.87	7.81	0.12	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	177.19	8.58	1.25	9.00	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	186.23	14.84	3.66	8.13	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	185.05	12.55	1.37	8.90	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	165.17	8.22	0.62	5.98	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	134.21	10.05	1.53	5.25	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	250.57	8.86	1.48	8.86	0.30	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	198.54	7.15	1.75	6.52	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	175.16	9.83	0.67	9.38	0.67	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	238.73	6.45	2.02	9.07	0.20	1.01
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	223.25	10.52	1.87	10.52	0.51	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	232.32	14.72	1.15	12.59	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	328.71	9.37	0.62	12.17	0.52	1.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	362.90	8.20	0.51	11.95	0.34	0.85
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	211.24	5.86	1.44	7.52	0.11	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	257.66	10.48	0.58	9.98	0.25	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	274.83	10.21	0.41	7.76	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	249.84	6.19	1.65	6.40	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	231.51	4.73	0.69	8.42	0.23	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	199.45	5.17	0.83	7.34	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	217.79	7.05	0.44	5.95	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	235.41	4.06	1.72	7.38	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	196.94	6.48	0.65	7.13	0.16	0.49
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	240.22	5.13	1.60	7.70	0.96	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	178.42	7.01	1.14	7.20	0.19	0.38
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	156.59	4.27	0.79	6.96	0.16	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	200.70	7.91	0.61	8.82	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	177.30	5.44	1.15	6.90	0.00	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	159.40	4.39	0.88	4.39	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	160.47	7.86	1.12	3.37	0.28	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	122.40	8.24	0.46	6.11	0.28	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	136.64	9.63	0.53	4.55	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	142.91	9.49	0.61	5.51	0.15	0.46
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	129.54	8.81	0.52	4.79	0.00	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	127.13	7.05	0.54	4.61	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	155.78	7.19	0.55	6.27	0.00	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	154.18	5.04	0.66	6.14	0.66	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	132.89	1.98	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	134.15	6.86	0.92	6.86	0.40	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	118.63	5.25	1.21	4.64	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	223.66	6.35	0.25	8.64	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	467.59	18.91	2.59	18.31	0.00	1.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	219.71	9.86	3.24	10.01	0.62	0.62
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	378.27	15.34	3.27	14.53	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	318.56	20.65	0.31	12.52	0.31	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	303.46	16.95	0.28	12.15	1.13	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	244.90	23.06	0.92	6.92	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	272.23	34.65	0.00	12.37	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	363.99	30.17	2.71	15.86	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	380.26	38.51	1.60	4.81	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	330.38	10.43	1.74	12.17	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	309.53	21.16	2.60	9.76	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	346.33	27.59	2.06	13.18	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	326.56	10.00	3.33	10.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	302.30	17.90	1.68	14.54	0.28	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	298.41	22.88	1.63	14.71	0.98	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	291.08	19.29	0.84	11.74	1.68	3.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	331.11	19.40	1.59	14.95	0.00	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	323.70	23.44	1.36	14.95	0.34	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	296.52	10.44	2.09	14.62	0.00	2.09
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	366.53	18.33	3.44	11.45	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	292.14	15.69	2.66	9.47	0.59	0.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	233.79	27.11	1.69	8.47	0.00	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	365.75	43.08	3.31	16.15	0.41	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	365.44	23.70	2.07	17.03	0.46	1.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	258.16	31.61	0.00	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	290.23	24.22	1.15	8.46	0.77	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	256.54	28.36	0.98	8.48	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	207.34	18.73	0.00	5.35	0.67	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	347.90	18.11	3.47	8.09	0.39	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	291.33	27.04	1.71	9.24	0.34	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	226.12	9.94	0.00	9.94	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	303.40	4.25	1.89	9.91	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	282.43	9.66	1.81	8.45	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	279.26	14.24	0.51	10.17	0.51	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	321.07	15.16	2.79	9.17	0.40	1.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	331.53	12.83	0.99	8.39	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	218.38	11.80	1.18	16.53	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	281.80	12.84	2.33	8.17	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	252.80	8.34	0.44	2.63	0.88	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	227.18	14.41	0.00	4.24	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	215.49	19.70	1.79	4.78	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	256.70	23.29	1.94	7.76	0.97	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	79.89	19.40	0.00	4.57	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	80.25	16.22	0.00	2.08	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	122.57	16.87	0.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	112.59	15.86	0.95	6.03	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	97.75	38.01	0.42	4.60	0.00	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	199.01	47.46	1.97	16.94	0.35	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	225.35	47.77	2.03	16.54	1.18	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	205.66	42.77	1.37	16.61	0.23	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	196.87	47.22	3.28	15.52	0.87	0.87
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	219.64	50.72	1.93	16.55	0.86	1.29
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	193.32	37.46	1.29	15.07	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	194.15	49.32	1.74	15.82	0.50	1.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	206.20	45.12	2.74	11.49	0.34	1.20
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	206.64	41.97	1.60	11.53	0.64	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	148.30	7.28	1.12	13.43	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	113.39	9.95	0.43	7.36	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	134.83	31.73	2.64	5.29	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	194.70	40.21	1.41	15.17	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	129.32	22.52	1.45	12.35	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	140.40	29.37	1.75	10.32	0.70	0.00
Hepatocyte, donor1	11523-119I2	110.16	1.21	0.00	6.05	0.00	0.00
Hepatocyte, donor2	11603-120I1	133.59	10.77	0.00	3.23	0.00	1.08
Hepatocyte, donor3	11684-122I1	93.87	4.91	1.23	6.14	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	269.56	5.22	5.87	14.36	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	243.47	23.25	1.75	13.63	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	172.47	22.78	0.27	10.15	0.27	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	28.66	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	53.40	20.03	0.00	13.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	71.99	23.53	1.38	6.92	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	52.56	12.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	189.89	35.60	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	58.95	12.81	0.00	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	50.28	27.42	0.00	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	61.72	30.86	0.00	9.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	93.37	36.68	0.00	5.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	47.20	18.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	88.67	39.70	0.00	7.94	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	86.47	34.37	0.00	3.33	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	47.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	68.03	24.56	1.26	4.41	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	89.70	37.12	0.00	6.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	57.50	24.55	0.65	4.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	53.13	27.37	1.61	6.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	35.84	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	80.67	36.67	0.81	4.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	79.34	28.55	0.42	6.72	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	61.88	27.33	0.80	5.63	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	62.78	19.39	1.85	5.54	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	79.77	33.51	1.42	6.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	52.60	21.77	1.81	5.44	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	51.65	31.21	2.15	3.23	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	72.42	45.74	0.00	8.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	49.29	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	49.74	31.88	0.64	6.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	78.37	38.28	0.00	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	15.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	57.84	26.42	0.71	3.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	49.77	13.27	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00	20.85
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	59.88	34.57	1.23	4.63	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	66.73	24.58	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	37.72	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	46.59	25.03	0.70	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	55.33	28.77	0.00	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	77.81	35.66	0.00	12.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	56.68	13.08	0.00	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	80.99	31.50	0.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	17.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	41.60	27.74	2.13	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	72.04	34.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	85.49	25.65	2.85	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	68.11	29.45	0.00	4.60	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	63.53	15.13	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	6.21	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	47.58	21.15	0.00	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	92.62	36.72	0.24	4.90	0.16	0.24
Keratinocyte - epidermal, donor2	11349-117G8	80.23	7.61	0.00	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	111.79	11.93	0.19	5.02	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	202.40	20.66	0.79	11.24	0.11	0.57
Keratocytes, donor1	11527-119I6	186.01	14.78	0.34	15.47	0.00	0.34
Keratocytes, donor2	11607-120I5	165.22	21.09	0.00	16.41	0.00	0.00
Keratocytes, donor3	11688-122I5	129.82	5.53	0.20	5.34	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	63.74	0.00	0.00	15.39	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	161.81	17.26	0.00	8.63	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	308.97	10.96	0.35	10.03	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	139.76	33.40	0.30	6.86	0.00	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	144.31	15.77	0.36	10.55	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	112.47	6.42	0.00	6.42	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	137.11	11.18	0.94	8.66	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	101.09	12.91	1.08	6.99	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	105.90	9.77	1.26	7.56	0.00	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	129.70	11.64	0.65	8.09	0.54	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	100.96	13.95	0.00	7.39	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	117.81	9.86	0.51	9.86	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	120.76	12.25	0.99	6.33	0.00	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	83.85	12.66	0.40	5.14	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	118.85	6.79	0.58	6.40	0.19	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	111.64	12.22	0.00	5.37	0.19	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	101.39	10.10	1.05	4.88	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	119.50	10.97	0.00	7.63	0.24	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	128.01	13.19	0.96	7.55	0.14	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	85.30	12.32	0.31	3.70	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	101.63	8.11	0.00	5.92	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	147.31	13.18	0.37	6.59	0.55	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	107.29	16.78	0.66	4.94	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	118.61	8.49	0.59	7.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	124.96	9.46	0.75	7.47	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	99.90	14.06	1.45	1.94	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	93.98	8.89	0.00	7.81	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	129.73	17.86	1.36	6.36	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	91.76	9.33	2.07	4.15	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	103.65	10.05	0.42	5.65	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	127.06	15.04	1.05	5.71	0.45	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	88.74	11.01	0.69	4.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	96.52	10.35	0.56	7.71	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	128.61	13.47	1.17	4.45	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	88.68	16.48	0.48	6.30	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	85.67	7.61	0.33	5.62	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	124.39	13.01	0.74	5.95	0.25	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	106.25	12.96	1.11	4.07	0.00	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	100.07	10.87	0.00	6.42	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	119.07	10.45	0.96	6.19	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	112.57	9.33	0.00	6.11	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	101.04	9.43	0.00	6.70	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	124.29	10.78	0.42	7.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	100.62	13.87	0.00	3.91	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	91.62	11.15	0.48	3.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	117.95	9.96	0.16	4.67	0.16	0.47
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	97.05	15.40	2.15	5.73	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	84.28	12.41	0.65	3.92	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	119.83	10.36	0.47	5.89	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	136.25	14.60	0.99	8.91	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	94.51	8.20	0.26	4.87	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	134.56	11.93	0.90	2.98	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	219.80	18.13	0.00	9.06	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	224.00	11.51	0.77	9.21	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	221.93	17.81	0.74	6.68	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	201.41	14.39	4.65	6.77	1.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	203.96	16.88	2.11	10.55	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	187.73	10.27	0.93	8.41	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	217.96	13.40	5.67	10.82	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	195.07	10.71	1.19	4.76	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	240.22	14.02	0.90	11.54	0.23	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	206.49	16.29	2.33	8.72	1.74	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	243.99	15.31	1.35	10.80	0.90	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	267.99	19.10	0.95	10.30	0.68	0.68
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	182.81	9.76	2.05	10.78	0.51	1.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	216.30	15.88	1.06	9.53	0.35	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	207.22	13.99	2.00	9.99	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	195.09	10.19	1.53	7.64	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	208.38	17.08	2.13	7.74	0.80	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	230.13	17.01	2.83	9.83	1.32	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	169.96	11.04	3.07	6.75	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	235.66	22.83	1.63	12.23	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	214.49	15.62	2.08	10.20	0.62	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	227.01	15.97	2.80	13.73	0.00	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	238.01	12.36	3.09	6.18	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	228.76	14.22	2.90	11.03	1.45	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	193.11	18.23	2.09	12.26	0.30	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	226.28	14.94	0.55	12.17	1.66	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	227.29	14.85	4.24	12.37	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	188.82	15.12	3.69	6.64	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	194.57	14.97	3.45	10.36	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	212.60	15.73	1.92	12.66	0.77	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	202.11	15.29	3.96	14.15	1.70	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	227.27	13.13	2.46	16.41	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	199.73	12.20	3.62	8.13	0.45	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	191.03	16.52	1.44	12.93	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	235.27	19.42	4.48	11.20	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	207.35	19.32	2.60	10.40	1.49	1.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	189.10	14.65	2.15	9.48	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	226.06	10.28	2.57	15.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	227.56	15.66	4.33	9.33	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	201.50	12.67	3.02	8.45	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	186.99	12.09	0.00	5.69	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	190.76	15.81	1.72	10.31	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	196.45	12.88	1.61	3.76	1.07	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	191.23	13.47	0.00	9.43	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	201.13	15.19	3.70	9.26	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	261.66	11.63	0.00	10.47	1.16	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	180.87	12.69	1.06	3.17	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	200.08	13.61	4.40	12.40	0.80	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	178.08	15.26	2.18	10.18	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	219.99	16.10	0.77	10.73	0.77	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	220.99	17.26	5.43	13.32	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	223.94	17.88	2.82	5.65	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	211.18	14.08	2.01	8.05	1.01	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	220.36	14.42	2.70	6.31	1.35	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	215.14	29.26	1.72	13.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	233.36	15.14	4.01	9.35	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	244.39	13.69	3.13	9.78	0.39	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	211.78	15.83	1.98	8.58	0.66	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	245.45	21.28	2.59	12.97	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	274.79	20.13	3.50	11.38	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	227.00	19.57	2.80	8.95	1.12	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	258.80	12.81	1.77	9.27	0.88	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	247.63	16.97	1.93	11.19	0.77	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	189.88	10.13	1.52	8.61	1.01	2.03
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	245.60	12.50	2.40	11.53	0.00	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	209.11	17.09	1.99	11.13	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	216.92	14.58	4.25	8.51	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	183.99	13.83	2.08	12.45	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	228.37	18.62	2.66	14.06	0.38	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	200.89	18.59	3.61	9.30	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	168.09	10.28	1.81	10.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	213.59	15.85	4.44	8.87	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	207.90	17.06	0.53	11.19	1.60	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	166.65	17.24	1.15	7.47	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	212.38	15.94	4.63	9.26	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	192.40	12.03	2.83	8.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	164.57	12.48	2.84	12.48	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	220.49	20.39	4.58	11.65	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	194.19	19.58	5.48	9.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	149.48	14.20	2.51	11.69	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	203.98	19.05	1.86	6.97	0.93	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	150.54	16.73	3.35	8.70	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	182.85	21.39	2.67	12.30	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	186.69	20.20	3.64	11.31	0.81	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	149.60	14.68	0.92	3.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	164.49	20.45	0.89	16.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	184.64	17.67	1.71	11.97	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	150.31	17.64	2.30	10.74	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	158.13	19.70	1.64	9.85	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	155.91	11.58	1.34	11.14	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	205.62	24.44	0.26	14.04	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	152.51	24.53	0.00	8.62	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	216.18	8.31	0.00	8.31	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	85.24	39.20	0.00	1.82	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	87.72	24.96	0.18	3.67	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	59.51	30.67	0.52	3.54	0.13	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	78.59	27.61	0.53	4.78	0.00	1.06
Mallassez-derived cells, donor2	11929-125I3	105.21	33.43	0.63	5.23	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	120.36	34.89	0.97	7.09	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	141.39	18.43	0.00	8.77	0.20	0.10
Mammary Epithelial Cell, donor2	11350-117G9	148.83	20.27	1.16	9.27	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	120.97	13.72	0.50	4.99	0.25	0.50
Mast cell - stimulated, donor1	11487-119E2	108.47	60.34	0.68	4.07	0.00	0.00
Mast cell, donor1	11563-120D6	154.53	26.39	0.43	6.60	0.11	0.43
Mast cell, donor2	11565-120D8	115.30	45.47	0.89	5.65	0.30	1.78
Mast cell, donor3	11566-120D9	110.09	40.30	0.68	5.63	0.45	0.23
Mast cell, donor4	11567-120E1	99.28	32.27	0.18	7.62	0.71	1.95
Mast cell, expanded and stimulated, donor5	11940-126A5	109.78	16.52	0.67	8.21	0.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	137.75	23.35	1.17	8.76	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	121.03	29.60	0.11	6.54	0.00	1.72
Mast cell, expanded, donor8	11941-126A6	153.81	24.94	0.33	4.69	0.17	1.84
Melanocyte - dark, donor1	11502-119F8	231.33	8.66	0.50	11.84	0.00	0.20
Melanocyte - dark, donor2	11582-120F7	124.94	25.26	0.69	5.54	0.69	0.69
Melanocyte - dark, donor3	11663-122F7	160.09	16.08	0.51	5.29	0.07	0.14
Melanocyte - light, donor1	11274-116H5	76.16	10.81	0.00	4.47	0.00	0.24
Melanocyte - light, donor2	11351-117H1	84.63	8.87	0.68	2.73	0.68	0.68
Melanocyte - light, donor3	11423-118G1	71.11	8.67	0.00	3.47	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	136.92	16.04	1.35	7.08	0.52	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	98.16	22.32	0.54	4.84	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	144.11	21.43	0.27	3.75	0.00	0.00
Meningeal Cells, donor1	11493-119E8	374.41	33.99	0.74	30.15	0.00	0.37
Meningeal Cells, donor2	11573-120E7	230.20	27.73	1.76	14.52	0.00	0.00
Meningeal Cells, donor3	11654-122E7	257.30	28.20	0.57	15.97	0.08	0.16
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	197.61	21.10	0.57	14.83	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	117.34	26.47	0.40	5.33	0.10	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	38.11	9.20	0.00	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	115.12	14.39	1.31	13.08	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	144.96	21.53	1.44	10.05	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	116.68	12.92	0.42	5.93	0.00	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	111.59	17.59	1.51	4.52	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	233.16	22.41	1.76	18.68	0.00	0.66
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	229.40	24.84	0.73	21.19	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	182.30	19.23	0.82	16.37	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	171.19	19.11	0.00	7.48	0.42	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	107.06	17.47	0.00	5.20	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	98.42	14.87	0.53	5.39	0.00	0.66
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	131.46	22.26	0.59	4.75	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	112.11	9.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	153.06	28.18	0.64	8.33	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	192.82	25.17	0.35	17.01	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	96.01	15.01	0.00	4.69	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	165.46	20.32	0.00	14.51	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	84.86	44.02	0.53	9.55	0.27	0.00
Mesothelial Cells, donor2	12156-128G5	102.10	45.04	0.50	8.51	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	60.05	31.58	0.79	4.99	0.22	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	99.92	74.27	0.00	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	86.93	36.20	1.23	2.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	69.79	27.97	0.29	3.83	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	20.74	0.00	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	53.93	27.59	1.24	4.34	0.00	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	60.99	30.29	0.41	1.87	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	46.32	23.16	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	89.59	23.77	1.50	1.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	65.63	35.38	0.93	4.19	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	58.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	67.47	29.26	0.20	1.63	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	65.33	23.76	0.79	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	25.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	64.60	24.78	1.77	2.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	81.31	27.74	0.00	2.66	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	36.85	18.42	0.00	3.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	65.37	26.32	0.42	2.12	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	33.15	19.34	0.00	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	59.91	19.97	1.19	1.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	33.53	20.12	1.68	3.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	63.48	21.58	1.25	2.26	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	53.24	25.43	0.71	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	25.43	16.59	0.55	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	49.27	17.73	0.23	1.38	0.00	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	53.01	25.66	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	36.28	14.06	0.00	2.04	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	51.06	22.96	0.43	1.93	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	40.46	20.67	0.44	2.45	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	30.01	12.48	0.00	1.75	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	24.84	12.67	0.00	1.52	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	29.83	23.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	29.90	14.40	0.00	1.63	0.82	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	43.52	14.41	0.00	2.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	25.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	25.95	16.82	0.48	1.44	0.96	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	30.42	29.62	0.40	0.40	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	42.51	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	35.54	22.53	0.00	1.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	134.74	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	36.69	34.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	41.16	23.65	0.00	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	29.80	29.80	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	37.14	39.06	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	47.10	44.87	1.24	1.49	0.99	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	28.53	27.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	39.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	55.38	52.65	0.34	2.05	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	36.32	34.57	0.44	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	51.49	59.30	0.71	1.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	70.42	56.67	0.84	3.37	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	32.83	24.94	0.00	1.25	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	43.71	65.85	1.17	2.33	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	54.00	42.84	2.11	2.11	0.90	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	52.59	34.64	1.25	2.50	0.00	0.83
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	50.53	79.41	0.00	7.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	51.72	54.49	2.77	3.69	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	63.17	39.27	1.14	2.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	58.31	64.12	1.11	1.93	0.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	57.79	61.16	1.04	2.85	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	59.20	46.76	0.43	3.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	32.39	71.14	0.00	1.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	48.57	62.45	1.60	1.60	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	44.00	35.02	0.90	2.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	39.55	50.00	0.28	1.41	0.28	0.42
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	52.55	64.34	1.27	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	59.93	43.78	0.66	3.32	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	41.71	59.53	0.38	1.14	0.76	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	64.21	53.98	1.14	2.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	51.86	29.00	0.25	0.74	0.00	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.24	44.97	0.65	4.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	50.28	52.34	0.88	1.18	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	39.21	32.87	0.58	0.58	0.00	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	65.53	72.13	0.82	1.24	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	38.71	43.48	1.49	2.38	0.00	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	79.10	30.14	3.77	0.00	0.00	3.77
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	71.29	10.69	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	93.31	28.26	0.66	1.97	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	74.69	12.62	0.00	2.10	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	66.03	15.81	0.20	0.79	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	71.71	9.31	0.00	5.59	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	78.49	18.78	1.50	2.25	0.00	1.13
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	59.13	10.65	0.80	1.33	0.27	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	95.34	27.71	0.45	3.62	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	69.25	23.58	0.74	3.68	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	68.52	21.99	0.00	2.93	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	74.67	18.67	1.56	3.11	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	88.18	29.93	0.53	3.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	69.55	11.59	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	91.90	29.29	2.02	2.02	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	54.39	16.44	1.69	1.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	12.26	0.00	2.72	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	15.26	8.27	0.00	1.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	22.68	8.91	0.81	0.00	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	9.06	0.00	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	17.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	32.62	29.36	0.00	3.26	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	23.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	0.00	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	118.49	27.58	0.65	5.82	0.22	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	171.42	12.02	1.57	5.23	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	68.08	14.02	0.67	4.67	0.00	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	43.82	24.21	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	186.34	55.33	2.09	9.70	0.95	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	218.63	43.09	0.00	17.55	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	28.56	8.16	0.68	2.04	0.68	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	628.47	106.58	7.35	31.24	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	52.32	10.88	0.00	0.84	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	53.93	19.99	0.23	5.11	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	54.32	12.97	0.00	2.70	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	117.94	18.29	0.63	5.05	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1247.09	122.48	0.00	33.40	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	61.05	11.91	0.50	3.47	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	105.29	14.62	0.81	3.25	0.27	1.08
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	53.04	11.33	0.45	2.04	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	55.85	9.96	0.16	1.80	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	113.73	14.22	0.55	3.28	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	70.55	11.67	0.00	2.65	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	54.03	12.01	0.00	1.20	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	214.63	46.60	2.63	8.20	0.33	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	49.11	7.64	0.16	2.76	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	115.88	14.82	0.88	3.88	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	47.12	7.74	0.70	2.11	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	60.68	8.73	0.00	2.30	0.00	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	65.88	5.78	0.32	2.89	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	243.15	53.11	2.07	9.31	0.00	1.03
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	1279.39	103.67	2.53	30.34	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	109.39	11.14	0.45	5.12	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	49.54	6.77	0.00	2.54	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	69.07	15.19	0.24	2.61	0.95	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	61.38	6.01	0.43	3.43	0.86	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1218.75	72.22	0.00	9.03	9.03	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	65.31	6.66	0.00	1.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	85.21	6.76	0.00	4.06	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	44.04	6.75	0.40	5.16	0.79	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	37.15	10.22	1.86	3.71	0.00	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	79.08	4.54	0.38	3.78	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	52.14	7.17	0.00	3.91	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	58.40	5.67	0.00	2.18	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	101.31	17.19	0.45	6.33	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	39.69	4.41	0.88	0.88	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	53.85	4.65	0.66	4.65	0.66	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	60.52	3.47	0.99	3.47	0.00	1.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	36.75	4.98	0.38	1.53	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	118.26	6.05	0.00	7.26	0.60	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	111.40	9.28	0.44	5.75	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	52.86	6.10	0.00	2.71	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	812.42	61.31	0.00	25.55	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	56.09	4.27	0.00	2.44	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	50.04	5.98	0.63	2.52	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	56.29	3.93	0.30	2.72	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	43.51	4.75	0.00	1.58	1.58	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	233.53	35.14	0.00	2.27	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	662.58	55.64	0.00	25.29	5.06	5.06
Myoblast, donor1	11241-116D8	90.31	30.56	0.99	6.83	0.25	0.37
Myoblast, donor2	11322-117D8	130.80	17.64	2.11	7.48	0.38	0.19
Myoblast, donor3	11398-118D3	144.28	32.79	0.50	11.77	0.00	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	111.64	1.90	0.29	6.86	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	96.87	11.99	0.00	4.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	68.45	9.95	0.60	2.41	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	70.86	9.02	0.18	2.21	0.37	0.00
Neural stem cells, donor1	11275-116H6	258.78	17.78	0.73	8.35	0.00	0.36
Neural stem cells, donor2	11352-117H2	358.17	15.41	0.00	5.78	0.00	0.00
Neurons, donor1	11494-119E9	333.40	12.52	4.55	12.52	2.28	0.00
Neurons, donor2	11574-120E8	341.03	11.01	1.76	14.97	0.00	0.44
Neurons, donor3	11655-122E8	227.74	2.47	3.29	11.51	1.64	0.00
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	264.78	12.59	0.59	5.70	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	146.85	12.70	0.00	3.58	0.33	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	141.39	11.43	0.00	7.82	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	90.30	10.05	0.41	2.48	0.14	0.41
Olfactory epithelial cells, donor2	11934-125I8	102.05	19.54	2.17	4.92	0.58	0.87
Olfactory epithelial cells, donor3	11935-125I9	91.14	15.44	0.91	3.41	0.45	0.34
Olfactory epithelial cells, donor4	11936-126A1	101.00	16.17	0.29	4.09	0.10	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	159.48	29.49	0.00	5.42	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	142.51	11.27	0.43	6.59	0.00	0.64
Osteoblast - differentiated, donor2	11353-117H3	117.74	14.86	1.14	2.29	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	117.93	5.59	2.48	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	291.40	28.92	0.59	17.39	0.00	0.39
Osteoblast, donor2	11354-117H4	186.82	25.99	1.40	7.02	0.00	0.00
Osteoblast, donor3	11426-118G4	140.23	18.48	0.53	9.06	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	140.34	29.23	0.76	7.16	0.17	0.25
Pericytes, donor1	11491-119E6	194.49	14.02	0.67	6.90	0.00	0.11
Pericytes, donor2	11571-120E5	165.02	7.92	0.23	7.92	0.45	0.00
Pericytes, donor3	11652-122E5	110.07	19.12	0.20	9.97	0.00	0.61
Perineurial Cells, donor1	11499-119F5	163.20	11.42	0.34	9.27	0.00	0.00
Perineurial Cells, donor2	11579-120F4	169.02	28.71	0.28	9.29	0.09	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	129.41	9.24	0.32	4.46	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	88.40	9.55	1.22	1.71	0.73	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	88.26	6.73	0.52	1.16	0.00	0.39
Placental Epithelial Cells, donor1	11278-116H9	92.32	6.94	0.24	8.37	0.00	0.96
Placental Epithelial Cells, donor2	11355-117H5	148.59	11.09	0.00	4.44	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	146.85	13.15	0.39	7.66	0.59	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	39.24	22.15	0.32	2.85	0.63	0.32
Preadipocyte - breast, donor1	11467-119B9	84.79	24.01	0.38	4.69	0.00	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	105.86	26.11	0.52	6.40	0.00	0.39
Preadipocyte - breast, donor2	11328-117E5	83.98	23.87	1.58	4.28	0.68	0.68
Preadipocyte - omental, donor1	11468-119C1	86.10	30.90	0.53	4.48	0.00	0.53
Preadipocyte - omental, donor2	11329-117E6	89.48	21.82	0.00	5.67	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	84.80	29.08	0.43	4.58	0.14	0.43
Preadipocyte - perirenal, donor1	11469-119C2	53.15	20.67	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	119.78	51.90	0.61	9.21	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	166.10	51.18	1.24	12.93	0.00	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	119.88	45.47	0.17	9.03	0.00	0.68
Preadipocyte - visceral, donor1	11280-116I2	183.31	54.86	1.02	13.97	0.19	0.37
Preadipocyte - visceral, donor2	11357-117H7	113.20	39.12	1.38	5.52	0.00	0.92
Preadipocyte - visceral, donor3	11429-118G7	112.43	36.68	0.84	8.88	0.42	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	211.80	11.62	1.66	12.97	0.45	0.91
Prostate Epithelial Cells, donor2	11331-117E8	55.11	21.94	0.41	3.66	0.27	0.41
Prostate Epithelial Cells, donor3	11404-118D9	65.52	4.78	0.43	6.55	0.24	0.49
Prostate Stromal Cells, donor1	11254-116F3	113.90	34.63	0.91	10.59	0.11	0.68
Prostate Stromal Cells, donor2	11332-117E9	115.29	27.79	1.79	8.61	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	85.09	18.77	1.25	4.80	0.10	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	250.74	9.12	1.09	20.44	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	139.04	9.77	0.14	10.54	0.14	0.07
Renal Epithelial Cells, donor1	11517-119H5	142.53	5.58	1.01	17.25	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	215.53	17.78	0.00	24.18	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	161.97	10.16	0.32	9.95	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	93.96	9.53	1.36	8.17	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	143.52	15.50	1.62	11.45	0.27	0.67
Renal Glomerular Endothelial Cells, donor3	11675-122H1	182.49	19.76	1.11	9.77	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	74.53	2.00	0.00	3.33	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	219.21	20.91	0.44	18.71	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	191.86	22.57	0.63	20.69	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	151.19	8.88	0.83	7.49	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	242.39	6.98	0.27	28.99	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	122.29	9.70	0.42	15.60	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	228.52	15.62	0.58	19.67	0.39	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	196.79	26.19	1.04	15.30	0.00	0.52
Retinal Pigment Epithelial Cells, donor1	11528-119I7	361.27	32.12	1.14	17.62	0.00	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	187.30	16.47	0.00	13.38	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	252.66	15.81	0.75	10.54	0.25	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	95.95	6.28	0.40	7.22	0.00	0.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	117.93	5.36	3.57	3.57	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	281.79	9.36	0.55	12.11	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	212.30	11.02	1.16	11.02	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	356.92	12.87	1.04	19.11	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	220.86	9.83	1.99	13.60	0.20	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	303.83	12.16	0.33	14.83	0.22	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	465.41	16.75	2.23	27.91	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	251.97	9.67	2.33	15.15	0.47	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	286.83	12.02	2.54	14.56	1.16	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	287.51	8.49	0.55	12.18	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	263.22	9.98	4.69	17.70	0.76	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	220.22	11.83	0.00	11.65	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	284.19	9.76	0.86	19.08	0.14	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	237.92	9.23	2.68	16.74	0.64	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	231.45	11.06	1.11	18.37	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	298.04	10.13	0.76	17.21	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	227.60	10.25	1.68	13.42	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	305.16	9.77	0.56	14.28	0.38	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	251.48	7.83	1.06	16.19	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	250.07	9.54	2.24	14.80	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	249.39	8.59	1.34	13.94	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	247.76	9.18	0.43	16.34	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	253.40	8.13	3.08	18.78	0.84	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	238.75	9.74	1.20	13.33	0.00	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	239.40	6.93	0.55	14.04	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	223.93	9.07	1.72	13.00	0.49	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	232.78	9.40	1.48	15.18	0.54	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	338.01	10.85	1.89	19.11	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	222.02	7.14	1.39	14.29	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	247.41	8.65	1.40	19.18	0.94	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	291.75	8.50	0.83	20.32	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	232.49	9.51	4.87	15.26	0.88	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	201.78	9.61	1.46	11.28	0.42	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	301.74	9.29	1.35	20.59	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	224.45	13.45	0.85	13.11	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	230.00	9.06	0.96	19.09	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	387.55	13.93	2.24	22.35	0.17	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	244.30	14.27	0.55	15.64	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	256.27	14.12	1.81	14.78	0.33	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	335.75	13.63	1.53	15.17	0.51	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	333.35	15.39	1.18	18.05	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	263.62	12.79	1.07	15.46	0.27	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	258.56	7.88	1.24	12.86	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	252.15	7.62	1.19	12.62	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	232.58	7.86	0.40	9.67	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	233.93	6.50	0.85	11.40	0.09	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	269.71	3.49	2.10	14.67	0.35	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	226.66	11.18	0.30	11.48	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	228.25	10.77	0.98	12.48	0.12	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	232.30	12.23	0.29	11.50	0.15	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	237.29	4.87	1.22	9.73	0.00	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	245.34	10.55	0.90	9.64	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	196.33	7.69	1.58	10.18	0.23	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	152.47	6.59	0.30	5.99	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	309.71	10.98	1.77	16.88	0.71	6.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	171.61	6.62	2.35	10.89	1.92	5.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	152.05	7.21	2.40	5.41	1.20	1.80
Schwann Cells, donor1	11498-119F4	170.58	8.84	0.75	11.85	0.56	0.19
Schwann Cells, donor2	11578-120F3	149.71	3.40	0.00	0.00	0.00	3.40
Schwann Cells, donor3	11659-122F3	156.42	15.34	0.88	8.11	0.66	0.00
Sebocyte, donor1	11220-116B5	181.86	47.66	0.55	9.86	0.55	0.55
Sebocyte, donor2	11301-117B5	119.02	31.25	1.38	6.89	0.00	0.00
Sebocyte, donor3	11378-118B1	100.38	16.08	1.44	6.80	0.62	0.41
Sertoli Cells, donor1	11255-116F4	97.74	26.51	0.00	6.63	0.00	0.00
Sertoli Cells, donor2	11333-117F1	98.85	33.89	5.65	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	352.62	7.04	0.53	19.44	0.09	0.97
Skeletal Muscle Cells, donor2	11358-117H8	148.18	6.51	1.45	4.34	1.45	0.72
Skeletal Muscle Cells, donor3	11430-118G8	147.98	19.23	0.84	11.70	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	202.97	18.22	1.26	19.64	0.00	0.47
Skeletal Muscle Cells, donor5	11455-119A6	179.12	19.77	1.78	17.24	0.30	0.30
Skeletal Muscle Cells, donor6	11459-119B1	189.15	14.01	1.23	22.78	0.00	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	236.51	26.59	0.76	10.58	0.50	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	171.51	18.26	1.57	11.27	1.00	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	241.48	18.95	1.19	19.84	0.20	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	249.30	15.59	0.76	13.14	0.00	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	146.92	11.58	0.00	15.20	0.00	1.45
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	165.39	16.79	2.34	9.91	0.00	0.00
Skin - palm, donor1	10286-104F7	104.76	2.69	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	42.53	11.53	0.58	3.32	0.00	0.29
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	74.43	15.54	0.00	0.82	0.00	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	49.85	11.81	0.26	4.67	0.13	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	67.56	14.32	0.14	5.56	0.14	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	70.75	10.13	0.84	4.50	0.14	0.56
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	103.19	12.48	0.42	9.09	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	53.96	6.30	0.45	4.05	0.00	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	96.59	39.19	0.31	5.86	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	57.14	24.68	0.67	5.78	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	87.00	21.75	0.00	2.94	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	69.61	20.55	0.00	4.42	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	98.05	42.92	0.79	5.12	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	95.80	21.63	0.00	7.73	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	219.17	12.01	2.00	3.00	0.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	89.96	20.09	0.27	5.06	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	91.76	32.58	0.44	4.43	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	60.17	31.50	1.02	5.63	0.38	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	142.93	25.07	0.00	4.56	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	126.40	32.19	0.30	5.91	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	69.47	27.90	0.14	3.84	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	128.68	23.10	0.49	11.39	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	135.17	8.52	0.61	3.96	0.30	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	146.74	15.91	0.00	6.57	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	24.48	0.00	12.24	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	62.47	10.97	1.43	6.20	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	109.72	27.87	1.18	8.70	0.44	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	95.35	28.84	0.86	4.52	0.86	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	112.93	27.08	0.63	9.97	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	106.73	42.69	0.31	11.14	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	67.91	49.58	1.08	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	73.22	26.60	0.90	8.07	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	160.80	18.44	0.34	17.41	0.68	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	180.46	13.11	0.31	4.95	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	67.93	46.29	0.91	5.74	0.20	0.50
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	69.18	33.91	0.46	3.64	0.46	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	41.66	14.49	1.81	8.45	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	343.87	29.41	1.32	40.00	0.26	2.65
Smooth Muscle Cells - Prostate, donor1	11257-116F6	128.23	20.11	0.53	10.39	0.13	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	105.56	30.93	2.25	5.13	0.13	0.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	108.31	30.44	0.25	4.31	0.51	1.27
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	118.36	38.30	0.30	7.84	0.15	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	95.27	11.25	0.75	6.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	71.07	12.92	1.29	10.34	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	79.99	30.69	0.00	6.05	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	57.05	23.22	0.00	5.05	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.37	24.44	0.94	2.19	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	107.08	31.56	0.29	7.96	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	241.01	28.07	0.33	25.08	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	121.93	13.55	0.93	4.20	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	88.80	25.62	0.14	7.20	0.00	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	86.68	16.32	1.78	5.86	0.25	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	81.98	18.62	0.94	6.58	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	188.24	30.32	0.98	16.91	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	127.44	28.66	0.42	9.64	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	39.05	2.86	0.00	1.90	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	74.62	24.71	0.49	6.61	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	85.73	32.04	0.66	7.95	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	112.35	16.97	0.29	7.90	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	95.82	11.27	0.58	2.72	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	49.19	20.89	0.26	1.59	0.53	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	113.07	36.45	0.37	2.60	0.37	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	70.79	27.31	1.44	3.23	0.36	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	53.66	26.12	0.57	3.97	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	146.52	16.15	0.79	6.70	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	97.77	19.30	0.51	4.57	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	79.86	8.39	0.00	1.60	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	77.75	21.32	0.42	3.34	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	90.30	10.54	0.46	4.58	0.46	0.46
Synoviocyte, donor1	11291-117A4	59.59	12.96	0.34	2.19	0.00	0.00
Synoviocyte, donor2	11368-117I9	111.47	12.24	0.84	2.51	0.50	0.67
Synoviocyte, donor3	11440-118H9	81.54	9.16	0.89	2.46	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	336.25	26.44	0.00	24.66	0.36	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	85.23	15.86	0.00	5.95	1.98	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	133.83	8.10	0.23	8.80	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	119.71	14.70	0.14	7.03	0.07	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	74.99	10.82	0.00	3.48	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	64.14	9.16	1.72	2.86	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	98.05	5.04	0.37	7.63	0.12	1.23
Urethra, donor2	10319-105A4	91.72	12.59	0.00	8.99	1.80	0.00
Urothelial Cells, donor1	11520-119H8	82.35	17.27	0.27	2.66	0.00	0.00
Urothelial Cells, donor2	11600-120H7	76.51	11.22	0.00	2.80	0.40	0.00
Urothelial Cells, donor3	11681-122H7	48.36	5.73	0.23	3.21	0.23	0.00
Urothelial cells, donor0	11216-116B1	75.12	10.70	0.67	2.45	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	146.81	8.90	0.89	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	117.23	11.44	0.00	4.29	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	80.77	7.53	0.68	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	141.18	7.92	0.00	4.82	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	127.25	5.81	0.58	2.91	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	119.74	9.37	0.00	4.16	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	161.53	10.10	0.92	4.59	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	65.73	6.39	0.91	1.83	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	161.85	27.63	0.49	11.72	0.25	0.25
Wilms' tumor cell line:HFWT	10597-108E3	176.01	16.72	0.00	14.08	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	97.48	4.47	0.28	5.03	0.00	0.28
achilles tendon, donor2	10292-104G4	55.80	4.13	0.00	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	281.98	18.87	1.78	17.59	0.00	1.02
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	412.34	16.72	0.70	20.43	0.93	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	289.53	11.04	0.71	13.30	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	396.47	24.76	2.72	30.75	0.27	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	365.97	16.02	5.06	25.02	0.00	1.69
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	476.04	18.40	0.63	35.95	0.00	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	420.57	39.47	4.90	19.87	1.36	1.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	439.76	40.54	2.20	19.39	0.88	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	497.79	19.19	2.86	35.53	0.82	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	370.05	27.18	3.11	22.13	0.78	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	568.01	48.39	4.97	53.36	1.10	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	518.77	27.30	0.00	11.70	3.90	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	394.82	8.83	1.86	30.67	0.93	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	574.76	24.34	3.88	33.66	0.78	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	470.22	36.82	5.26	32.44	0.29	1.75
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	155.23	13.48	1.39	8.37	0.46	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	190.41	20.56	1.65	9.87	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	114.19	68.45	1.84	11.97	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	284.19	124.60	0.85	45.66	0.43	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	289.34	133.45	2.43	41.55	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	323.51	133.83	1.20	42.85	0.72	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	233.43	26.73	1.78	25.17	0.45	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	198.46	14.34	0.33	18.35	0.33	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	217.41	50.17	0.00	20.44	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	242.19	68.18	1.51	23.35	1.51	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	434.39	24.42	0.87	18.32	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	187.45	76.85	1.87	18.74	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	187.69	14.37	0.71	12.01	0.00	0.47
adipose tissue, adult, pool1	10010-101C1	106.88	9.15	0.31	5.74	0.16	0.93
adipose, donor1	10184-103D4	710.73	58.64	2.93	18.18	0.59	2.93
adipose, donor2	10185-103D5	84.35	11.35	0.41	4.06	0.41	2.43
adipose, donor3	10186-103D6	155.20	11.71	1.09	7.62	0.00	0.82
adipose, donor4	10187-103D7	256.56	13.87	0.00	15.60	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	173.13	8.05	1.10	9.47	0.16	0.63
adrenal gland, adult, pool1	10081-102A9	61.84	14.55	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	99.79	3.07	0.40	5.60	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	188.65	13.22	0.36	10.36	0.00	0.71
amniotic membrane cells, donor1	12235-129G3	62.14	5.56	0.70	3.25	0.46	0.00
amniotic membrane cells, donor2	12236-129G4	105.83	7.44	0.00	4.40	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	79.54	5.30	0.59	4.42	0.00	0.29
amygdala - adult, donor10196	10167-103B5	107.91	11.86	0.00	3.56	0.00	0.00
amygdala, adult, donor10252	10151-102I7	103.01	10.95	0.61	3.65	0.20	0.20
amygdala, newborn, donor10223	10360-105E9	56.48	12.91	0.32	4.20	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	280.89	5.22	0.38	12.10	0.13	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	199.44	26.92	0.66	12.58	0.44	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	352.41	8.02	0.00	10.69	0.00	0.67
aorta, adult, pool1	10052-101G7	62.37	3.53	0.00	3.33	0.78	0.20
appendix, adult	10189-103D9	117.60	4.66	0.00	7.76	0.39	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	308.85	7.91	1.72	14.79	0.34	0.34
artery, adult	10190-103E1	86.96	2.72	0.00	2.72	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	214.11	5.65	0.29	9.42	0.14	0.29
b cell line:RPMI1788	10427-106D4	202.53	6.99	0.15	8.92	0.00	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	56.04	22.75	0.00	3.61	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	159.56	5.46	0.69	15.28	0.00	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	227.63	3.18	0.33	25.94	0.33	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	482.62	35.23	2.24	16.78	0.00	1.68
bladder, adult, pool1	10011-101C2	104.95	4.13	0.33	4.56	0.00	0.54
blood, adult, pool1	10053-101G8	81.94	8.86	0.00	4.43	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	87.35	14.56	0.00	2.57	0.00	0.00
bone marrow, adult	10192-103E3	95.83	4.72	5.40	4.72	0.67	0.00
brain, adult, donor1	10084-102B3	68.68	4.10	0.00	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	100.33	14.70	0.56	4.23	0.00	0.56
brain, fetal, pool1	10085-102B4	181.66	18.70	2.67	10.69	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	329.04	37.99	3.96	16.85	0.00	0.33
breast carcinoma cell line:MDA-MB-453	10419-106C5	208.08	10.98	0.25	8.99	0.00	0.00
breast, adult, donor1	10080-102A8	33.46	1.26	0.00	5.68	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	221.81	11.56	0.64	24.77	0.13	0.38
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	237.79	21.34	0.00	15.15	0.62	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	233.90	26.48	0.00	19.34	0.69	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	126.61	17.43	0.48	7.99	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	155.63	5.64	0.47	11.75	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	115.83	3.72	0.33	7.22	0.11	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	189.50	9.51	0.32	6.02	0.00	0.95
carcinosarcoma cell line:JHUCS-1	10642-109A3	292.80	29.01	1.86	10.11	0.80	0.27
caudate nucleus - adult, donor10196	10177-103C6	108.22	16.12	0.00	3.45	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	93.70	5.19	0.67	2.84	0.17	0.17
caudate nucleus, adult, donor10258	10379-105H1	70.30	11.46	1.53	5.35	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	73.25	10.25	0.37	1.83	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	122.36	5.83	0.00	5.83	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	92.66	1.28	0.85	4.27	0.43	0.00
cerebellum, adult, pool1	10083-102B2	67.26	3.10	0.00	5.17	0.34	0.69
cerebellum, newborn, donor10223	10357-105E6	140.32	6.64	1.66	4.15	0.00	0.00
cerebral meninges, adult	10188-103D8	86.23	14.62	0.76	6.81	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	58.47	7.31	2.19	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	244.57	18.98	0.58	17.83	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	123.46	8.45	0.66	5.14	0.50	0.00
cervix, adult, pool1	10013-101C4	133.65	5.04	0.42	4.09	0.10	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	125.13	5.71	0.14	11.29	0.00	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	101.89	16.98	0.00	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	306.96	15.29	1.24	20.13	0.25	1.12
choriocarcinoma cell line:SCH	10785-110H2	319.24	20.45	0.86	15.52	0.00	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	209.43	17.79	0.00	23.72	0.00	0.95
chorionic membrane cells, donor1	12238-129G6	51.86	2.28	0.57	2.56	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	99.73	14.82	0.40	4.87	0.10	0.80
chorionic membrane cells, donor3	12240-129G8	69.24	3.85	0.55	9.34	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	90.88	10.10	1.01	5.05	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	228.02	24.97	0.96	18.63	0.38	0.77
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	134.74	23.02	0.21	9.93	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	112.22	43.14	0.77	8.22	0.51	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	123.60	49.59	1.21	8.22	0.48	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	97.53	49.68	0.20	8.14	0.20	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	121.90	47.11	0.29	15.61	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	476.94	37.27	0.00	22.94	0.26	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	154.52	6.17	2.51	8.23	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	118.68	2.78	0.52	9.20	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	190.91	28.92	0.55	12.08	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	622.19	9.88	1.52	30.03	0.00	0.38
colon, adult, donor1	10082-102B1	97.58	3.57	1.19	2.38	0.00	0.00
colon, adult, pool1	10014-101C5	121.62	18.57	0.35	4.00	0.12	0.82
colon, fetal, donor1	10070-101I7	90.23	4.94	1.24	2.47	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	105.42	22.92	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	525.77	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	165.30	28.47	0.85	9.77	2.55	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	275.00	43.92	0.91	14.49	0.75	0.75
cord blood derived cell line:COBL-a untreated	10449-106F8	342.80	62.33	0.71	12.69	0.42	0.28
corpus callosum, adult, pool1	10042-101F6	145.06	8.18	0.22	6.74	0.00	0.11
cruciate ligament, donor2	10295-104G7	72.13	6.48	1.62	4.86	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	55.38	1.61	0.00	6.42	0.80	0.00
diencephalon, adult	10193-103E4	105.35	4.56	1.20	3.36	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	356.13	9.87	8.04	15.84	1.84	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	304.14	15.13	1.03	14.62	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	125.66	31.78	0.96	9.63	0.00	0.24
ductus deferens, adult	10196-103E7	80.23	8.47	1.00	3.49	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	79.21	8.64	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	147.13	8.09	2.21	8.09	0.00	0.74
dura mater, adult, donor1	10041-101F5	130.32	20.15	0.50	5.62	0.00	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	160.78	6.00	0.00	18.21	0.22	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	211.50	15.19	0.72	24.36	0.57	0.57
embryonic pancreas cell line:1B2C6	10604-108F1	147.37	3.08	0.00	24.66	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	114.12	1.82	0.61	10.29	0.30	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	147.89	6.17	1.23	20.69	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	236.42	7.88	1.31	24.96	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	287.60	26.82	1.01	26.48	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	262.97	7.61	0.54	17.58	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	181.40	23.64	2.73	13.35	0.16	0.64
epidermoid carcinoma cell line:A431	10426-106D3	142.95	14.90	0.11	7.78	0.00	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	132.42	6.38	0.22	8.36	0.11	0.11
epididymis, adult	10197-103E8	84.98	7.54	0.63	3.35	0.21	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	155.23	18.27	0.53	8.69	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	69.60	32.64	0.79	9.44	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	275.60	18.48	3.01	17.30	0.26	0.13
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	238.18	13.58	2.26	10.73	0.20	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	255.54	17.81	1.90	20.17	0.78	0.56
esophagus, adult, pool1	10015-101C6	99.91	6.37	0.53	5.52	0.11	1.17
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	305.70	33.31	0.50	19.66	0.13	0.88
eye - muscle inferior rectus, donor1	10272-104E2	53.12	2.41	0.00	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	46.29	0.00	0.00	4.21	0.00	0.00
eye - muscle medial, donor2	10299-104H2	50.60	0.00	2.98	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	68.79	2.29	1.15	2.29	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	58.30	8.74	0.00	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	83.90	5.08	0.51	4.32	0.00	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	124.63	4.87	0.38	9.49	0.26	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	181.86	12.58	0.47	21.61	0.24	0.47
frontal lobe, adult, pool1	10040-101F4	108.93	16.14	0.09	5.25	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	279.83	29.42	1.80	18.32	1.20	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	104.33	4.94	0.27	14.90	0.00	0.09
gall bladder, adult	10198-103E9	119.99	11.35	1.21	7.48	0.48	1.21
gamma delta positive T cells, donor1	11937-126A2	168.57	5.37	0.00	4.29	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	117.65	9.71	0.37	2.61	0.00	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	93.36	1.48	1.69	2.96	0.21	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	188.58	8.90	0.39	14.51	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	314.14	15.41	0.66	16.56	0.33	0.00
gastric cancer cell line:GSS	10560-108A2	117.15	2.75	0.92	8.24	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	287.63	5.71	3.66	12.34	0.69	0.23
giant cell carcinoma cell line:LU65	10487-107B1	136.31	4.36	0.34	12.62	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	223.65	15.12	0.84	16.52	0.00	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	132.94	17.21	1.25	15.71	0.75	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	70.83	12.14	0.63	4.12	0.00	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	70.78	10.25	0.42	6.32	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	89.18	10.15	0.33	5.96	0.00	0.33
glioma cell line:GI-1	10413-106B8	201.79	10.54	0.29	10.25	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	70.70	7.29	0.00	4.37	0.73	0.73
globus pallidus, adult, donor10252	10161-103A8	131.32	6.83	1.22	6.10	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	50.66	4.11	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	65.55	5.33	0.00	0.53	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	100.33	24.47	0.00	7.34	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	469.92	54.64	0.00	54.64	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	663.78	114.98	0.00	31.36	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	86.08	12.80	1.60	3.84	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	275.47	9.18	1.38	10.10	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	247.84	11.89	2.29	11.43	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	252.48	11.59	0.00	9.02	0.00	0.00
hIPS, biol_rep1	14380-156B6	290.33	11.50	5.75	4.31	1.44	0.00
hIPS, biol_rep2	14381-156B7	257.20	9.60	0.69	4.80	1.37	2.74
hIPS, biol_rep3	14382-156B8	129.11	15.45	0.00	4.41	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	236.48	13.79	0.29	13.79	0.29	0.86
heart - mitral valve, adult	10205-103F7	55.61	1.49	0.60	7.18	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	78.18	2.35	0.26	6.28	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	76.60	3.33	0.00	5.83	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	82.03	8.77	0.82	4.90	0.41	0.20
heart, adult, diseased, donor1	10051-101G6	77.08	2.98	1.28	3.83	0.00	0.00
heart, adult, pool1	10016-101C7	79.34	4.37	0.23	6.44	0.00	0.00
heart, fetal, pool1	10046-101G1	136.77	3.80	0.10	6.67	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	39.18	12.34	0.00	1.54	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	422.16	19.03	2.38	27.35	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	345.63	24.75	2.54	16.46	0.55	0.88
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	360.97	25.00	3.03	18.93	0.61	0.61
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	373.90	25.97	2.83	16.47	0.71	0.61
hepatoma cell line:Li-7	10484-107A7	242.34	10.12	0.67	11.46	0.00	0.33
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	289.94	10.35	0.90	13.67	0.20	0.30
hippocampus - adult, donor10196	10169-103B7	85.17	15.14	0.95	2.84	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	111.64	8.78	1.02	3.06	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	102.08	13.94	1.00	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	62.04	10.22	1.76	5.99	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	707.39	17.70	11.60	27.47	0.61	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	321.04	8.25	2.36	16.30	0.79	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	365.86	10.16	3.81	14.47	1.78	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	177.62	16.92	2.82	1.69	0.00	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	226.71	15.75	6.46	4.13	0.77	2.07
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	254.72	15.94	1.14	3.42	0.76	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	157.95	10.22	0.00	2.92	1.17	2.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	167.60	7.97	1.08	6.25	0.43	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	142.22	15.01	1.25	6.67	0.42	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	293.86	13.97	0.47	10.66	0.24	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	223.72	11.73	1.29	10.13	0.80	3.86
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	238.35	12.79	0.67	9.43	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	294.97	6.89	2.35	13.46	0.63	1.10
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	437.25	9.83	11.79	16.70	1.97	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	502.71	18.33	2.62	21.82	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	226.80	26.92	1.34	6.30	0.38	2.86
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	225.89	18.32	2.62	6.54	0.87	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	272.37	25.49	1.00	7.50	1.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	124.53	13.38	0.94	4.90	0.75	3.39
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	134.60	15.92	0.45	5.46	0.45	1.82
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	122.16	16.91	0.31	5.64	0.63	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	170.81	13.72	0.82	5.39	0.65	1.96
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	151.25	14.52	0.87	4.64	0.00	2.61
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	139.30	18.83	2.09	5.38	0.00	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	312.40	7.39	2.40	14.41	1.11	1.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	301.55	8.56	1.43	16.55	0.29	3.42
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	444.65	9.80	2.04	17.97	0.82	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	246.10	20.42	1.41	7.75	0.70	2.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	179.59	14.25	1.58	4.75	0.00	2.85
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	206.99	20.58	0.61	8.47	0.30	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	139.62	14.48	0.00	7.76	0.52	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	144.12	19.92	1.99	5.31	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	132.88	16.42	0.77	5.64	0.00	2.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	206.31	17.90	2.30	7.16	0.77	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	217.32	24.23	1.51	6.82	0.76	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	159.96	26.55	1.34	6.05	1.01	2.35
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	308.89	7.73	3.38	13.28	0.97	1.69
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	353.85	11.59	4.46	11.14	0.89	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	278.54	9.27	3.90	14.15	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	228.30	19.56	1.83	7.95	1.53	3.06
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2130.87	74.82	19.52	48.80	6.51	19.52
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	287.26	26.81	1.32	10.59	0.33	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	179.51	9.30	1.09	9.85	0.00	3.83
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	158.87	11.94	1.09	5.07	0.36	2.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	139.50	11.03	1.07	4.98	0.00	4.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	208.84	7.16	2.39	5.97	0.00	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	295.09	16.12	0.95	10.56	0.27	3.11
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	153.56	13.74	0.54	5.93	0.54	1.35
immature langerhans cells, donor1	11904-125F5	105.58	54.73	1.94	2.42	0.24	0.00
immature langerhans cells, donor2	11905-125F6	65.75	30.89	0.00	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	118.01	21.20	0.38	5.77	0.19	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	100.15	11.06	0.65	11.38	0.33	0.00
kidney, adult, pool1	10017-101C8	122.26	7.51	0.40	8.21	0.20	0.20
kidney, fetal, pool1	10045-101F9	192.47	4.24	0.35	11.46	0.00	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	171.56	10.51	0.43	12.92	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	209.57	5.81	1.11	7.88	1.80	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	114.50	6.42	0.00	11.38	0.00	0.00
left atrium, adult, donor1	10079-102A7	50.67	3.81	0.54	2.18	0.00	0.00
left ventricle, adult, donor1	10078-102A6	50.06	4.55	0.00	3.54	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	148.57	40.77	0.82	12.86	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	58.92	40.24	0.72	4.67	0.00	1.80
leiomyoma cell line:15242A	10570-108B3	44.57	36.41	0.00	5.43	0.54	0.00
leiomyoma cell line:15425	10571-108B4	61.68	30.59	1.94	6.56	0.24	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	63.49	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	35.55	5.23	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	169.77	29.51	0.59	8.26	0.24	0.47
liposarcoma cell line:KMLS-1	10782-110G8	59.36	16.25	0.31	3.12	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	122.69	9.75	0.37	6.82	0.00	0.12
liver, adult, pool1	10018-101C9	122.68	10.37	0.16	9.72	0.32	1.78
liver, fetal, pool1	10086-102B5	57.38	9.41	0.00	2.82	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	78.75	7.58	0.44	2.77	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	94.31	5.17	1.11	3.69	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	52.76	5.36	0.56	2.82	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	106.00	10.94	0.84	7.99	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	208.98	11.21	0.14	10.38	0.42	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	106.17	4.83	0.00	8.27	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	167.01	18.19	0.26	13.18	0.40	0.40
lung, adult, pool1	10019-101D1	96.39	7.80	0.47	3.07	0.47	1.30
lung, fetal, donor1	10068-101I5	180.09	10.85	0.29	9.70	0.00	0.29
lung, right lower lobe, adult, donor1	10075-102A3	65.52	5.96	0.00	2.75	0.00	0.92
lymph node, adult, donor1	10077-102A5	88.99	9.47	0.95	6.15	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	137.64	5.04	0.66	3.95	0.22	0.66
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	240.43	8.30	1.36	26.41	0.60	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	180.94	29.73	0.00	16.99	0.00	0.00
mature adipocyte, donor1	12231-129F8	99.90	14.21	0.00	9.77	0.44	0.44
mature adipocyte, donor2	12232-129F9	88.82	6.02	0.42	5.19	0.21	0.21
mature adipocyte, donor3	12233-129G1	127.78	13.75	0.00	6.87	0.47	0.24
mature adipocyte, donor4	12234-129G2	157.67	18.16	0.00	7.37	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	139.14	1.67	0.24	29.31	0.00	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	83.47	19.18	1.13	3.38	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	97.47	11.40	0.37	3.31	0.00	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	87.05	13.03	0.64	2.86	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	142.02	43.08	3.84	8.10	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	91.97	20.59	1.86	6.24	0.68	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	104.41	9.76	1.06	3.40	0.00	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	109.80	0.00	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	531.08	43.06	14.35	43.06	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	60.66	23.33	1.44	3.95	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	70.74	5.19	0.00	4.54	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	105.89	5.26	0.15	4.02	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	106.93	6.94	0.16	5.47	0.24	0.08
medulla oblongata, newborn, donor10223	10361-105F1	71.52	4.86	0.69	4.51	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	294.48	33.43	1.99	11.51	0.44	0.66
medulloblastoma cell line:ONS-76	10759-110E3	196.37	9.90	0.24	13.57	0.12	0.24
melanoma cell line:COLO 679	10514-107E1	131.96	9.63	0.29	4.74	0.14	0.43
melanoma cell line:G-361	10465-106H6	108.59	6.52	0.54	6.79	0.00	0.81
meningioma cell line:HKBMM	10691-109F7	92.62	3.62	1.63	9.59	0.54	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	342.77	48.46	6.17	22.91	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	264.41	12.18	2.59	9.85	0.78	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	165.10	55.39	0.61	9.36	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	162.69	41.26	0.18	6.36	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	124.64	34.78	1.24	6.21	0.41	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	119.40	20.93	0.84	4.92	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	129.02	22.15	0.96	5.39	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	81.90	14.58	2.08	8.33	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	84.96	18.19	0.51	3.78	0.00	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	109.50	26.91	0.35	6.44	0.23	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	143.91	46.16	0.93	9.15	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	121.00	35.38	0.68	9.32	0.54	0.41
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	121.35	32.01	0.57	6.54	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	93.54	8.89	0.00	3.29	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	110.70	30.03	1.11	6.50	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	94.25	23.74	2.09	6.63	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	74.32	25.32	0.00	4.49	0.41	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	71.17	12.58	0.72	3.24	0.00	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	88.55	21.41	0.93	4.66	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	46.51	32.83	1.37	3.65	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	194.67	90.62	1.26	20.14	0.42	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	117.61	24.66	1.05	4.78	0.00	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	129.37	25.30	0.79	7.88	0.26	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	103.08	11.04	0.37	4.79	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	72.11	21.18	0.57	3.15	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	190.30	29.47	5.05	9.26	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	119.19	20.09	0.46	5.94	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	142.22	21.23	0.26	5.63	0.26	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	119.36	22.25	0.52	4.19	0.26	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	112.76	20.33	1.54	6.16	0.31	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	141.21	25.89	1.41	6.83	0.47	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	120.83	23.69	1.35	4.74	0.34	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	118.68	20.43	0.39	6.29	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	132.99	23.63	0.00	5.56	0.00	1.85
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	289.82	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	152.57	34.61	0.29	8.65	0.00	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	126.94	22.09	0.00	6.02	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	122.34	22.11	0.48	4.81	0.00	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	160.60	21.27	1.47	5.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	114.46	19.80	1.34	5.37	0.00	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	108.08	24.15	0.82	6.55	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	120.28	24.06	0.43	7.30	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	106.64	19.14	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	41.32	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	97.44	20.14	1.95	4.22	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	97.48	30.55	1.45	7.27	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	116.74	25.59	1.60	4.26	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	117.76	17.99	2.45	4.09	0.82	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	100.29	20.21	1.17	2.72	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	102.84	12.59	0.00	6.30	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	115.24	18.88	2.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	81.04	33.37	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	117.41	18.97	0.59	4.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	140.12	23.15	3.66	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	189.37	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	119.71	15.83	0.63	6.33	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	134.51	14.83	0.34	4.83	0.00	1.03
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	113.91	17.19	0.00	2.15	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	207.57	27.94	7.98	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	220.41	17.22	3.44	6.89	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	197.62	10.19	0.41	5.30	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	199.40	9.53	2.38	6.36	1.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	178.63	6.48	1.18	4.13	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	168.94	8.10	0.62	2.49	0.31	1.25
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	185.80	5.35	4.01	4.01	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	183.31	18.92	0.00	10.64	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	184.90	20.54	5.14	7.70	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	198.95	11.70	0.00	8.95	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	187.53	18.80	0.99	9.90	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	155.89	12.34	0.00	10.09	0.00	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	190.18	15.27	0.64	7.63	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	145.07	18.94	0.40	8.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	111.21	6.54	0.00	8.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	149.51	15.20	1.27	7.60	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	122.59	12.14	0.61	3.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	140.09	18.08	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	129.32	8.24	0.82	6.59	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	109.13	11.11	0.00	3.17	0.00	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	114.55	13.63	0.32	8.11	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	123.25	15.28	2.04	9.17	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	117.60	22.44	0.77	3.87	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	66.62	11.81	0.24	8.74	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	116.30	64.64	0.23	6.49	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	119.66	21.37	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	87.75	30.52	0.31	5.75	0.21	0.41
mesothelioma cell line:Mero-25	10850-111F4	131.63	13.62	1.36	12.26	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	101.95	12.47	1.22	11.73	0.49	0.24
mesothelioma cell line:Mero-48a	10852-111F6	73.96	9.08	0.22	4.43	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	118.00	18.40	0.53	4.99	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	137.88	17.19	1.87	6.81	0.17	0.34
mesothelioma cell line:Mero-84	10855-111F9	132.20	18.71	1.01	6.57	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	144.10	23.81	0.41	9.94	0.00	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	84.81	10.60	0.33	8.61	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	112.21	23.17	0.36	6.33	0.00	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	88.32	14.01	0.34	6.32	0.17	0.34
mesothelioma cell line:NCI-H28	10845-111E8	132.32	9.92	0.76	6.62	0.00	0.25
mesothelioma cell line:No36	10857-111G2	110.58	12.40	0.65	6.85	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	60.96	11.38	0.54	2.71	0.27	0.27
migratory langerhans cells, donor1	11901-125F2	55.66	11.13	0.38	4.22	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	44.69	7.94	0.12	4.52	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	144.12	41.28	0.18	6.46	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	131.90	4.57	2.29	8.81	1.31	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	170.18	15.47	1.70	9.54	0.21	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	70.95	11.29	0.00	5.99	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	139.29	6.66	0.76	9.32	0.76	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	556.04	7.02	1.85	29.20	1.11	0.92
myeloma cell line:PCM6	10474-106I6	138.17	6.52	0.59	12.65	0.20	0.59
myxofibrosarcoma cell line:MFH-ino	10600-108E6	244.01	42.61	2.54	9.13	0.00	1.01
myxofibrosarcoma cell line:NMFH-1	10684-109E9	302.84	11.18	1.96	14.91	0.39	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	94.49	4.79	0.11	11.48	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	93.84	5.96	0.37	8.97	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	98.25	11.04	0.00	4.42	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	826.15	11.50	0.92	26.69	0.00	0.69
neuroblastoma cell line:NB-1	10539-107G8	329.64	49.58	0.37	20.21	0.19	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	139.61	5.06	0.42	6.12	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	653.91	8.20	4.10	15.65	0.37	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	551.31	5.46	4.74	14.23	1.42	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	302.35	15.84	2.22	12.99	1.11	1.58
neuroectodermal tumor cell line:TASK1	10774-110F9	473.56	22.94	1.21	18.52	0.60	1.41
neuroepithelioma cell line:SK-N-MC	10728-110A8	229.51	25.43	0.00	8.90	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	71.86	18.63	0.27	3.19	0.27	0.27
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	28.41	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	320.48	14.54	1.01	14.21	0.34	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	177.71	17.61	0.80	11.21	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	93.30	14.11	0.64	5.77	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	73.57	15.50	1.84	4.47	0.26	0.79
nucleus accumbens, adult, pool1	10037-101F1	108.17	11.15	0.19	4.78	0.09	0.19
occipital cortex - adult, donor10196	10172-103C1	98.90	14.42	2.06	4.12	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	108.42	5.64	1.34	2.15	0.27	0.27
occipital cortex, newborn, donor10223	10355-105E4	61.87	17.47	0.73	3.64	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	76.62	10.50	0.26	4.46	1.31	0.79
occipital lobe, fetal, donor1	10073-102A1	185.80	5.58	1.29	13.73	0.00	0.86
occipital pole, adult, pool1	10036-101E9	107.70	12.14	0.24	5.05	0.00	0.00
olfactory region, adult	10195-103E6	83.30	10.51	0.57	4.01	0.00	0.19
optic nerve, donor1	10277-104E7	84.04	6.00	0.00	8.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	137.83	7.29	0.11	8.54	0.00	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	181.08	2.61	0.14	10.85	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	173.05	15.92	3.89	6.77	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	99.34	8.55	0.35	5.66	0.23	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	80.25	3.53	0.59	5.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	272.83	8.41	0.00	12.15	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	294.55	8.27	0.42	25.66	0.00	0.42
ovary, adult, pool1	10020-101D2	144.74	4.11	0.26	9.35	0.09	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	126.67	14.12	0.00	7.52	0.37	0.00
pancreas, adult, donor1	10049-101G4	104.41	0.94	0.94	5.64	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	193.16	17.05	0.56	14.82	0.28	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	119.93	5.62	3.24	10.73	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	133.62	3.31	0.17	7.62	0.00	0.17
paracentral gyrus, adult, pool1	10035-101E8	103.69	15.92	0.27	5.40	0.09	0.18
parietal cortex, adult, donor10258	10373-105G4	76.34	13.21	0.73	2.20	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	79.94	11.29	0.00	1.88	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	102.90	5.99	0.29	3.42	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	104.51	14.19	0.26	6.43	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	240.52	4.85	1.94	12.61	0.00	2.91
parietal lobe, newborn, donor10223	10356-105E5	55.71	19.81	0.37	4.11	0.00	0.00
parotid gland, adult	10199-103F1	90.65	3.08	0.00	2.47	0.62	0.00
penis, adult	10200-103F2	109.03	3.76	0.54	4.83	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	230.37	3.35	1.86	9.11	0.37	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	168.28	12.09	0.58	9.32	0.00	0.73
pineal gland - adult, donor10196	10179-103C8	94.82	37.41	1.94	6.45	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	139.17	8.88	0.59	6.51	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	89.04	10.03	0.00	5.02	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	98.14	4.05	1.01	4.05	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	109.97	6.25	0.52	8.34	0.52	0.00
pituitary gland, adult, donor10258	10378-105G9	80.87	11.07	0.00	7.66	0.00	0.85
placenta, adult, pool1	10021-101D3	70.41	7.42	0.00	5.27	0.00	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	158.51	7.95	1.59	7.95	0.13	0.26
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	49.80	4.67	0.00	2.02	0.16	0.00
pons, adult, pool1	10033-101E6	99.06	10.67	0.17	5.59	0.09	0.17
postcentral gyrus, adult, pool1	10032-101E5	112.89	15.08	0.35	5.06	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	125.48	35.55	0.00	10.46	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	567.33	55.08	0.00	27.54	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	481.17	140.83	0.00	58.68	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	174.50	20.10	1.17	17.04	0.15	0.29
prostate cancer cell line:PC-3	10439-106E7	192.03	28.68	0.73	12.71	0.00	0.00
prostate, adult, pool1	10022-101D4	103.39	2.81	0.36	6.35	0.00	0.63
putamen, adult, donor10196	10176-103C5	109.53	12.75	1.42	2.83	0.00	0.24
putamen, adult, donor10252	10152-102I8	78.43	7.84	1.96	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	149.71	12.02	0.00	6.56	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	86.26	8.46	0.72	5.32	0.00	0.00
putamen, newborn, donor10223	10365-105F5	128.94	11.99	0.75	3.00	0.75	0.75
rectal cancer cell line:TT1TKB	10469-106I1	219.95	10.76	0.00	18.04	0.00	0.00
rectum, fetal, donor1	10067-101I4	118.23	1.39	0.00	5.56	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	101.97	5.94	0.00	11.02	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.58	6.63	0.00	3.31	0.41	0.00
retina, adult, pool1	10030-101E3	123.06	10.64	0.30	6.66	0.00	0.30
retinoblastoma cell line:Y79	10475-106I7	285.78	79.76	1.30	14.03	0.52	1.04
rhabdomyosarcoma cell line:KYM-1	10787-110H4	187.87	24.84	0.37	9.34	0.12	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	260.11	13.50	0.84	13.22	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	126.56	9.85	0.00	3.79	0.00	0.00
salivary acinar cells, donor1	11771-123I7	175.13	25.25	1.13	4.69	0.49	0.65
salivary acinar cells, donor2	11772-123I8	166.88	15.28	1.93	4.68	0.69	0.41
salivary acinar cells, donor3	11773-123I9	136.38	14.57	0.66	3.97	0.00	0.00
salivary gland, adult, pool1	10093-102C3	122.40	4.00	0.57	7.44	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	205.30	8.68	0.76	16.95	0.08	0.34
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	213.00	7.88	0.47	20.34	0.24	0.12
seminal vesicle, adult	10201-103F3	101.58	14.28	2.12	4.76	2.12	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	49.31	4.62	0.49	4.13	0.00	0.49
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	71.72	5.03	0.75	5.79	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	139.49	6.02	1.00	12.04	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	233.85	3.63	1.34	14.91	0.13	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	133.08	4.53	0.22	7.96	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	156.38	23.74	0.39	8.77	0.13	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	137.61	5.67	2.84	12.06	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	125.57	3.12	0.00	8.88	0.48	0.36
skeletal muscle, fetal, donor1	10066-101I3	124.62	3.02	0.00	9.05	1.01	0.00
skin, adult, donor1	10074-102A2	88.21	6.79	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	116.15	5.68	2.52	5.05	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	163.09	12.67	1.00	8.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	355.55	7.88	3.47	9.14	0.63	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	211.83	8.29	1.16	21.01	0.77	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	257.13	8.24	1.48	8.41	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	232.91	20.11	2.25	9.97	0.64	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	334.07	10.02	1.09	14.38	0.22	0.00
small intestine, adult, pool1	10024-101D6	112.28	24.37	0.00	5.73	0.24	1.55
small intestine, fetal, donor1	10064-101I1	144.96	17.44	1.72	9.09	0.74	0.74
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	83.60	10.26	4.62	5.13	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	84.26	3.88	0.00	2.07	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	120.07	24.12	0.80	2.95	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	80.29	9.64	0.92	4.13	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	118.68	5.52	0.39	3.15	0.00	0.39
spinal cord, adult, donor10258	10369-105F9	149.43	7.61	2.08	11.07	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	122.58	2.44	0.00	4.27	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	154.30	12.40	0.92	5.97	0.46	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	69.30	21.51	0.30	5.08	0.15	0.15
spleen, adult, pool1	10025-101D7	132.16	8.37	0.11	7.60	0.22	1.10
spleen, fetal, pool1	10044-101F8	138.81	9.93	0.32	6.99	0.00	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	133.01	4.76	0.72	8.70	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	262.60	21.65	0.57	12.34	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	152.71	25.86	2.45	7.69	0.35	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	147.77	14.07	0.00	7.43	0.00	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	194.73	3.04	0.45	17.11	0.11	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	72.44	9.74	0.00	5.51	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	75.73	24.54	0.00	5.08	0.00	0.00
stomach, fetal, donor1	10062-101H8	127.09	21.36	2.14	7.48	0.00	1.07
submaxillary gland, adult	10202-103F4	68.93	5.13	0.57	3.42	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	100.32	1.87	1.45	3.32	0.21	0.21
substantia nigra, adult, donor10258	10371-105G2	88.45	9.31	0.00	3.62	0.00	0.52
substantia nigra, newborn, donor10223	10358-105E7	68.54	4.24	0.00	2.12	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	225.83	14.21	0.92	22.70	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	114.78	19.16	0.17	4.83	0.00	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	259.98	7.83	2.14	9.26	1.42	2.14
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	244.82	7.03	2.20	10.99	0.88	1.32
tenocyte, donor1	11763-123H8	117.65	17.11	1.05	5.93	0.70	0.70
tenocyte, donor2	11765-123I1	137.34	9.54	1.14	4.58	0.00	0.76
tenocyte, donor3	11768-123I4	102.30	22.98	2.97	4.82	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	278.57	26.34	0.68	16.32	0.17	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	319.70	23.74	0.77	18.96	0.62	0.46
teratocarcinoma cell line:PA-1	10807-111A6	264.70	3.72	0.93	11.93	0.77	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	250.98	18.28	1.27	17.52	0.25	0.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	234.09	4.92	0.76	11.72	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	369.83	11.23	1.20	26.17	0.87	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	132.56	1.95	1.95	10.75	0.00	0.33
testis, adult, pool1	10026-101D8	86.43	8.59	0.54	6.76	0.21	3.33
testis, adult, pool2	10096-102C6	76.23	7.67	0.90	9.92	0.45	0.45
thalamus - adult, donor10196	10168-103B6	99.36	14.35	0.00	8.83	0.00	0.00
thalamus, adult, donor10252	10154-103A1	104.87	3.44	0.63	6.72	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	127.79	9.24	0.00	6.16	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	50.56	5.11	0.33	1.81	0.16	0.66
thalamus, newborn, donor10223	10366-105F6	88.60	20.14	1.73	4.03	0.00	0.00
throat, adult	10209-103G2	86.39	5.24	1.25	7.74	0.50	0.25
throat, fetal, donor1	10061-101H7	120.36	3.96	1.52	6.70	0.91	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	249.41	58.82	0.79	8.74	0.40	0.00
thymus, adult, pool1	10027-101D9	219.01	9.54	0.40	8.35	0.20	2.19
thymus, fetal, pool1	10043-101F7	137.67	9.25	0.31	5.82	0.31	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	113.95	8.38	0.27	9.44	0.00	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	287.90	6.29	0.70	20.81	0.84	0.98
thyroid, adult, pool1	10028-101E1	161.62	5.69	0.37	9.14	0.00	0.56
thyroid, fetal, donor1	10060-101H6	82.53	3.16	1.05	6.33	0.79	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	101.63	3.08	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	90.71	6.98	1.16	3.72	0.23	0.93
tongue, fetal, donor1	10059-101H5	84.34	3.15	0.79	4.34	0.00	0.39
tonsil, adult, pool1	10047-101G2	148.06	9.72	0.20	7.61	0.00	0.50
trachea, adult, pool1	10029-101E2	103.15	4.66	0.25	8.02	0.08	0.33
trachea, fetal, donor1	10058-101H4	90.79	3.08	0.38	3.08	1.15	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	95.30	18.42	0.35	4.96	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	235.97	5.37	0.41	10.54	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	272.32	22.25	0.63	23.66	0.47	0.63
tridermal teratoma cell line:HGRT	10694-109G1	123.66	24.73	0.00	3.81	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	158.21	6.01	0.59	7.87	0.00	0.08
umbilical cord, fetal, donor1	10057-101H3	47.99	8.35	0.00	4.17	0.00	0.00
uterus, adult, pool1	10100-102D1	164.66	4.27	0.17	10.41	0.00	0.00
uterus, fetal, donor1	10055-101H1	140.27	4.10	1.02	6.66	0.00	0.00
vagina, adult	10204-103F6	41.36	0.65	0.65	4.52	0.00	0.00
vein, adult	10191-103E2	108.28	4.82	0.66	4.16	0.00	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	177.85	7.21	1.60	6.14	0.00	0.00